Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

RGD DISEASE ONTOLOGY - ANNOTATIONS

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term:Neoplastic Processes
go back to main search page
Accession:DOID:9008192 term browser browse the term
Definition:The pathological mechanisms and forms taken by tissue during degeneration into a neoplasm and its subsequent activity.
Synonyms:primary_id: MESH:D009385


show annotations for term's descendants           Sort by:
Neoplastic Processes term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G APOBEC3B apolipoprotein B mRNA editing enzyme catalytic subunit 3B ISO CTD Direct Evidence: marker/mechanism CTD PMID:26258849 NCBI chr 5:9,098,676...9,115,965
Ensembl chr 5:9,097,719...9,116,369 		JBrowse link
G CHAF1B chromatin assembly factor 1 subunit B ISO protein:increased expression:: RGD PMID:22882088 RGD:9587477 NCBI chr13:200,048,096...200,074,902
Ensembl chr13:200,048,149...200,072,556 		JBrowse link
G ERG ETS transcription factor ERG ISO CTD Direct Evidence: marker/mechanism CTD PMID:27783944 NCBI chr13:201,999,237...202,302,572
Ensembl chr13:202,000,995...202,301,368 		JBrowse link
G ETV1 ETS variant transcription factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27783944 NCBI chr 9:83,322,818...83,567,136
Ensembl chr 9:83,322,823...83,418,902 		JBrowse link
G ETV4 ETS variant transcription factor 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27783944 NCBI chr12:19,531,507...19,548,303
Ensembl chr12:19,531,603...19,548,301 		JBrowse link
G ETV5 ETS variant transcription factor 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27783944 NCBI chr13:123,873,346...123,930,292
Ensembl chr13:123,873,350...123,930,200 		JBrowse link
G EWSR1 EWS RNA binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27783944 NCBI chr14:46,408,636...46,439,357
Ensembl chr14:46,408,649...46,439,453 		JBrowse link
G HDLBP high density lipoprotein binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:25129143 NCBI chr15:139,957,703...140,025,336
Ensembl chr15:139,957,715...140,022,302 		JBrowse link
G HOXD9 homeobox D9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26075790 NCBI chr15:81,910,415...81,926,276
Ensembl chr15:81,924,142...81,926,274 		JBrowse link
G HRAS HRas proto-oncogene, GTPase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12082015 NCBI chr 2:299,662...302,539
Ensembl chr 2:299,660...302,501 		JBrowse link
Anaplasia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CA9 carbonic anhydrase 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19808899 NCBI chr 1:236,393,727...236,400,994
Ensembl chr 1:236,394,306...236,400,822 		JBrowse link
G HIF1A hypoxia inducible factor 1 subunit alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:19808899 NCBI chr 1:190,625,436...190,673,926
Ensembl chr 1:190,625,244...190,674,845 		JBrowse link
Blast Crisis term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AICDA activation induced cytidine deaminase ISO CTD Direct Evidence: marker/mechanism CTD PMID:21570118 NCBI chr 5:62,777,236...62,787,342
Ensembl chr 5:62,777,352...62,787,369 		JBrowse link
G BCR BCR activator of RhoGEF and GTPase ISO CTD Direct Evidence: marker/mechanism CTD PMID:21570118 NCBI chr14:49,208,662...49,322,109
Ensembl chr14:49,208,762...49,322,103 		JBrowse link
G ESR2 estrogen receptor 2 ISO RGD PMID:12740446 RGD:734951 NCBI chr 1:193,823,666...193,907,330
Ensembl chr 1:193,829,560...193,906,565 		JBrowse link
G HMOX1 heme oxygenase 1 ISO RGD PMID:22139798 RGD:10755566
G MIR150-1 microRNA mir-150-1 ISO miRNA:decreased expression:leukocytes RGD PMID:21501493 RGD:13782140 NCBI chr 6:54,580,912...54,580,988
Ensembl chr 6:54,580,912...54,580,988 		JBrowse link
G TCN2 transcobalamin 2 ISO protein:increased expression:: RGD PMID:1059479 RGD:11060122 NCBI chr14:47,496,245...47,515,966
Ensembl chr14:47,502,715...47,515,965 		JBrowse link
Bone Metastasis term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ALOX12 arachidonate 12-lipoxygenase, 12S type ISO associated with Prostatic Neoplasms; RGD PMID:14669797 RGD:1578303 NCBI chr12:52,401,861...52,414,913
Ensembl chr12:52,401,810...52,414,903 		JBrowse link
G BRIP1 BRCA1 interacting helicase 1 ISO associated with Breast Neoplasms; human gene in a mouse model RGD PMID:22875853 RGD:11252149 NCBI chr12:36,498,138...36,639,847
Ensembl chr12:36,498,205...36,635,973 		JBrowse link
G CXCR4 C-X-C motif chemokine receptor 4 disease_progression ISO associated with hepatocellular carcinoma;protein:increased expression:liver (human) RGD PMID:19508713 RGD:152023653 NCBI chr15:15,663,652...15,666,706
Ensembl chr15:15,663,494...15,667,232 		JBrowse link
G ENPP1 ectonucleotide pyrophosphatase/phosphodiesterase 1 ISO associated with Breast Neoplasms;mRNA:increased expression:bone element (human) RGD PMID:23861746 RGD:13204736 NCBI chr 1:31,724,290...31,796,594
Ensembl chr 1:31,722,721...31,796,595 		JBrowse link
G MMP13 matrix metallopeptidase 13 ISO associated with Carcinoma, Renal Cell; mRNA, protein:increased expression:bone (human) RGD PMID:18709334 RGD:2306080 NCBI chr 9:33,549,003...33,616,700
Ensembl chr 9:33,549,008...33,561,162 		JBrowse link
G PDGFD platelet derived growth factor D ISO associated with prostate carcinoma RGD PMID:22158043 RGD:13506772 NCBI chr 9:34,388,636...34,621,227
Ensembl chr 9:34,388,643...34,621,244 		JBrowse link
Carcinogenesis term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:23968727 NCBI chr 1:270,761,641...270,906,708
Ensembl chr 1:270,761,668...270,906,708 		JBrowse link
G ADPRH ADP-ribosylarginine hydrolase ISO RGD PMID:21697277 RGD:13838723 NCBI chr13:140,638,526...140,681,631
Ensembl chr13:140,673,101...140,681,260 		JBrowse link
G AKR1A1 aldo-keto reductase family 1 member A1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:32805337 NCBI chr 6:165,811,245...165,825,168
Ensembl chr 6:165,811,247...165,824,896 		JBrowse link
G AKT1 AKT serine/threonine kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:32045588
G BRAF B-Raf proto-oncogene, serine/threonine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:24717435 NCBI chr18:8,957,963...9,132,558
Ensembl chr18:8,957,991...9,132,553 		JBrowse link
G CAV1 caveolin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29247004 NCBI chr18:29,648,120...29,682,451
Ensembl chr18:29,649,992...29,682,465 		JBrowse link
G CDKN2A cyclin dependent kinase inhibitor 2A ISO CTD Direct Evidence: marker/mechanism CTD PMID:21526190 NCBI chr 1:200,774,496...200,799,149
Ensembl chr 1:200,792,469...200,798,854 		JBrowse link
G CUX1 cut like homeobox 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24316979 NCBI chr 3:9,317,145...9,669,999
Ensembl chr 3:9,317,140...9,669,998 		JBrowse link
G DNMT1 DNA methyltransferase 1 disease_progression ISO RGD PMID:21163286 RGD:9588222 NCBI chr 2:68,981,564...69,040,364
Ensembl chr 2:68,981,566...69,029,844 		JBrowse link
G DNMT3A DNA methyltransferase 3 alpha disease_progression ISO RGD PMID:21163286 RGD:9588222 NCBI chr 3:113,501,972...113,609,148
Ensembl chr 3:113,528,926...113,603,087 		JBrowse link
G EPAS1 endothelial PAS domain protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26735578 NCBI chr 3:94,167,759...94,253,662
Ensembl chr 3:94,165,816...94,254,079 		JBrowse link
G ERBB2 erb-b2 receptor tyrosine kinase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25221644 NCBI chr12:22,591,621...22,621,384
Ensembl chr12:22,590,725...22,621,351 		JBrowse link
G GATA3 GATA binding protein 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:35115686 NCBI chr10:63,367,684...63,397,977
Ensembl chr10:63,367,663...63,388,859 		JBrowse link
G ISG15 ISG15 ubiquitin like modifier ISO CTD Direct Evidence: marker/mechanism CTD PMID:35506701 NCBI chr 6:63,363,201...63,364,211
Ensembl chr 6:63,363,173...63,364,208 		JBrowse link
G KRAS KRAS proto-oncogene, GTPase ISO CTD Direct Evidence: marker/mechanism CTD PMID:26595770 PMID:29247004 NCBI chr 5:48,508,774...48,546,260
Ensembl chr 5:48,508,811...48,549,358 		JBrowse link
G MAP3K8 mitogen-activated protein kinase kinase kinase 8 ISO RGD PMID:15287022 PMID:23533274 RGD:151356924 RGD:151356978 NCBI chr10:40,714,004...40,746,390
Ensembl chr10:40,713,847...40,742,462 		JBrowse link
G MET MET proto-oncogene, receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:32045588 NCBI chr18:29,426,044...29,541,526
Ensembl chr18:29,426,048...29,541,512 		JBrowse link
G MIR143 microRNA mir-143 ISO CTD Direct Evidence: therapeutic CTD PMID:28736328 NCBI chr 2:150,578,738...150,578,817
Ensembl chr 2:150,578,738...150,578,817 		JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29228771 NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,656...83,146,183 		JBrowse link
G PAFAH1B1 platelet activating factor acetylhydrolase 1b regulatory subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24487275 NCBI chr12:48,567,329...48,735,836
Ensembl chr12:48,628,816...48,735,834 		JBrowse link
G POU5F1 POU class 5 homeobox 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:35506701 NCBI chr 7:23,564,654...23,570,691 JBrowse link
G SPARC secreted protein acidic and cysteine rich ISO CTD Direct Evidence: marker/mechanism CTD PMID:26783756 NCBI chr16:71,368,164...71,380,972
Ensembl chr16:71,357,586...71,381,161 		JBrowse link
G TNFSF8 TNF superfamily member 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11552987 NCBI chr 1:255,436,206...255,459,020
Ensembl chr 1:255,432,969...255,459,073 		JBrowse link
Circulating Neoplastic Cells term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ERBB2 erb-b2 receptor tyrosine kinase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29044505 NCBI chr12:22,591,621...22,621,384
Ensembl chr12:22,590,725...22,621,351 		JBrowse link
Liver Metastasis term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACE angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 ISO associated with colorectal cancer;mRNA:increased expression:liver (mouse) RGD PMID:20380732 RGD:25671446 NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703 		JBrowse link
G BRAF B-Raf proto-oncogene, serine/threonine kinase severity ISO associated with colorectal cancer;DNA:mutations:multiple
associated with colorectal cancer;DNA:mutation:cds:
associated with colorectal cancer;DNA:missense mutation:cds:p.V600E (human)
associated with skin melanoma;DNA:missense mutations:cds:
associated with colorectal cancer;DNA:missense mutations:cds:pV599E,p.V600E (human)		 RGD PMID:22331825 PMID:23010994 PMID:26775732 PMID:27737491 PMID:28787433 RGD:11554843 RGD:14696791 RGD:15039394 RGD:18337264 RGD:18337265 NCBI chr18:8,957,963...9,132,558
Ensembl chr18:8,957,991...9,132,553 		JBrowse link
G CCL2 chemokine (C-C motif) ligand 2 disease_progression ISO associated with colorectal cancer RGD PMID:27058904 RGD:14995463 NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026 		JBrowse link
G CCL5 C-C motif chemokine ligand 5 treatment ISO associated with Animal Mammary Neoplasms; RGD PMID:15692764 RGD:14995455 NCBI chr12:39,652,731...39,659,121
Ensembl chr12:39,648,598...39,659,118 		JBrowse link
G CCND2 cyclin D2 ISO associated with colorectal cancer;protein:increased expression:colorectum RGD PMID:19508551 RGD:151665111 NCBI chr 5:66,092,483...66,114,575
Ensembl chr 5:66,087,379...66,114,571 		JBrowse link
G CCNG1 cyclin G1 treatment ISO human cells in mouse model RGD PMID:10910035 RGD:151356987 NCBI chr16:60,349,255...60,356,737
Ensembl chr16:60,349,258...60,356,738 		JBrowse link
G CD44 CD44 molecule ISO associated with Breast Neoplasm;protein:increased expression:liver RGD PMID:17991717 RGD:2289349 NCBI chr 2:25,788,699...25,884,209
Ensembl chr 2:25,788,703...25,884,153 		JBrowse link
G CHD4 chromodomain helicase DNA binding protein 4 ameliorates ISO associated with human colon adenocarcinoma cells in a mouse model RGD PMID:28486105 RGD:153323299 NCBI chr 5:64,071,627...64,105,212
Ensembl chr 5:64,065,992...64,105,173 		JBrowse link
G CXCL10 C-X-C motif chemokine ligand 10 treatment ISO associated with colon carcinoma; RGD PMID:30381616 RGD:27095891 NCBI chr 8:71,693,641...71,695,948
Ensembl chr 8:71,693,339...71,695,948 		JBrowse link
G CXCL12 C-X-C motif chemokine ligand 12 ameliorates ISO associated with colorectal cancer; human cells in mouse model RGD PMID:30789971 RGD:151893289 NCBI chr14:91,516,383...91,543,857
Ensembl chr14:91,516,431...91,552,752 		JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 ISO associated with colorectal cancer; human colon adenocarcinoma cells in a mouse model RGD PMID:29679563 RGD:26884358 NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861 		JBrowse link
G CXCR4 C-X-C motif chemokine receptor 4 ameliorates ISO associated with colorectal cancer; human cells in mouse model
human cells in mouse model; associated with colorectal cancer		 RGD PMID:29436696 PMID:30789971 RGD:151893289 RGD:152023643 NCBI chr15:15,663,652...15,666,706
Ensembl chr15:15,663,494...15,667,232 		JBrowse link
G DAXX death domain associated protein exacerbates ISO associated with colon cancer; mRNA:decreased expression:liver (human)
associated with pancreatic endocrine carcinoma;DNA:mutations:CDS:multiple (human)
associated with neuroendocrine tumor;DNA:mutations:CDS:multiple (human)		 RGD PMID:30339629 PMID:30342802 PMID:31942198 RGD:152025194 RGD:152025199 RGD:152025203 NCBI chr 7:29,676,854...29,681,145
Ensembl chr 7:29,676,856...29,681,110 		JBrowse link
G DDR1 discoidin domain receptor tyrosine kinase 1 treatment ISO mRNA:increased expression:liver (mouse)
human cells in mouse model; nilotinib		 RGD PMID:29438985 PMID:30666650 PMID:33110221 RGD:151347537 RGD:151347685 RGD:151347840 NCBI chr 7:23,371,358...23,391,585
Ensembl chr 7:23,373,845...23,391,584 		JBrowse link
G DDR2 discoidin domain receptor tyrosine kinase 2 ameliorates ISO associated with colon carcinoma
associated with melanoma;		 RGD PMID:21701781 PMID:22071959 RGD:150429701 RGD:150429713 NCBI chr 4:87,749,738...87,911,818
Ensembl chr 4:87,756,168...87,911,296 		JBrowse link
G DOCK6 dedicator of cytokinesis 6 ameliorates ISO associated with stomach cancer; RGD PMID:29587866 RGD:155791564 NCBI chr 2:69,925,853...69,972,326
Ensembl chr 2:69,925,854...69,972,316 		JBrowse link
G FBXW7 F-box and WD repeat domain containing 7 disease_progression ISO associated with colorectal cancer; RGD PMID:28846828 RGD:21408566 NCBI chr 8:76,482,027...76,699,354
Ensembl chr 8:76,482,844...76,699,348 		JBrowse link
G FGFR1 fibroblast growth factor receptor 1 ISO associated with colorectal cancer;mRNA:increased expression:colorectal mucosa: RGD PMID:19082464 RGD:25330357 NCBI chr15:48,053,895...48,106,634
Ensembl chr15:48,053,340...48,106,724 		JBrowse link
G FOSL2 FOS like 2, AP-1 transcription factor subunit ISO human cells in mouse model RGD PMID:30114390 RGD:153344554 NCBI chr 3:110,820,403...110,842,903
Ensembl chr 3:110,823,666...110,843,068 		JBrowse link
G GPC3 glypican 3 ISO protein:increased expression:blood serum (human) RGD PMID:28801286 RGD:243065135 NCBI chr  X:109,536,495...109,973,605
Ensembl chr  X:109,536,504...109,973,607 		JBrowse link
G HMBS hydroxymethylbilane synthase ISO associated with colon adenocarcinoma;protein:decreased activity:liver(rat) RGD PMID:1386052 RGD:25440496 NCBI chr 9:46,300,039...46,308,681
Ensembl chr 9:46,300,050...46,308,868 		JBrowse link
G IL2 interleukin 2 treatment ISO associated with Colorectal Neoplasms, Carcinoma, Hepatocellular;
associated with colon carcinoma		 RGD PMID:9354462 PMID:11591892 RGD:14928215 RGD:8663446 NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609 		JBrowse link
G IQSEC1 IQ motif and Sec7 domain ArfGEF 1 ISO human cells in mouse model RGD PMID:22662237 RGD:153344589 NCBI chr13:71,203,967...71,366,685
Ensembl chr13:71,031,001...71,366,684 		JBrowse link
G MAP2K7 mitogen-activated protein kinase kinase 7 ISO associated with colon cancer;protein:increased expression:colon (human) RGD PMID:24533778 RGD:155259116 NCBI chr 2:71,299,010...71,308,432
Ensembl chr 2:71,298,325...71,308,124 		JBrowse link
G MIR148B microRNA mir-148b exacerbates ISO associated with stomach cancer; RGD PMID:29587866 RGD:155791564 NCBI chr 5:19,530,990...19,531,069
Ensembl chr 5:19,530,985...19,531,074 		JBrowse link
G MIR155 microRNA mir-155 ISO RGD PMID:26885061 RGD:21079444 NCBI chr13:189,138,822...189,138,902
Ensembl chr13:189,138,822...189,138,902 		JBrowse link
G MPL MPL proto-oncogene, thrombopoietin receptor exacerbates
severity		 ISO associated with pancreatic cancer; protein:increased expression:liver, pancreas (human)
associated with colorectal carcinoma;protein:increased expression:colorectum (human)
associated with pancreatic ductal adenocarcinoma; human cells in mouse model		 RGD PMID:23747337 PMID:30770989 RGD:126925751 RGD:126925752 NCBI chr 6:167,896,191...167,908,988
Ensembl chr 6:167,896,287...167,908,625 		JBrowse link
G NRAS NRAS proto-oncogene, GTPase susceptibility ISO associated with colorectal cancer;DNA:mutations:exons (human)
associated with melanoma;DNA:mutations: exons (human)
human gene in a mouse model;DNA:missense mutations:cds:p.G12V, p.Q61K (human)		 RGD PMID:26799184 PMID:28011498 PMID:28787433 RGD:14696774 RGD:14696791 RGD:14696792 NCBI chr 4:105,845,913...105,853,769
Ensembl chr 4:105,845,872...105,858,227 		JBrowse link
G PTPRB protein tyrosine phosphatase receptor type B treatment ISO mouse tumor cells in mouse recipient RGD PMID:31348125 RGD:151660353 NCBI chr 5:34,656,460...34,794,838
Ensembl chr 5:34,659,964...34,794,289 		JBrowse link
G RICTOR RPTOR independent companion of MTOR complex 2 disease_progression ISO mRNA:increased expression:liver (human) RGD PMID:30404068 RGD:152995463 NCBI chr16:24,109,934...24,250,019
Ensembl chr16:24,109,939...24,311,132 		JBrowse link
G RNF43 ring finger protein 43 ISO associated with colorectal adenocarcinoma;mRNA:increased expression:liver (human) RGD PMID:28789449 RGD:151361221 NCBI chr12:34,631,574...34,695,021
Ensembl chr12:34,635,228...34,694,378 		JBrowse link
G SLC3A2 solute carrier family 3 member 2 severity ISO associated with colon adenocarcinoma RGD PMID:11745822 RGD:151361130 NCBI chr 2:8,892,071...8,919,070
Ensembl chr 2:8,892,089...8,919,072 		JBrowse link
G SLC7A5 solute carrier family 7 member 5 severity ISO associated with colon adenocarcinoma
associated with colon cancer		 RGD PMID:11718450 PMID:11745822 RGD:151361129 RGD:151361130 NCBI chr 6:1,545,940...1,574,298
Ensembl chr 6:1,545,944...1,574,285 		JBrowse link
G SMAD4 SMAD family member 4 treatment ISO associated with colorectal carcinoma;protein:decreased expression:colorectum:
associated with colorectal carcinoma; DNA:mutations: :		 RGD PMID:17390050 PMID:29551247 RGD:18937000 RGD:21066338 NCBI chr 1:100,521,843...100,633,501
Ensembl chr 1:100,589,850...100,628,029 		JBrowse link
G SOX30 SRY-box transcription factor 30 ameliorates ISO RGD PMID:29739711 RGD:151660333 NCBI chr16:65,642,107...65,677,693
Ensembl chr16:65,642,223...65,678,047 		JBrowse link
G SRC SRC proto-oncogene, non-receptor tyrosine kinase disease_progression ISO associated with colon cancer;protein:increased activity:colon RGD PMID:7678609 RGD:150521542 NCBI chr17:40,470,970...40,524,862
Ensembl chr17:40,471,009...40,524,860 		JBrowse link
G VEGFA vascular endothelial growth factor A ISO associated with colorectal carcinoma;mRNA,protein:increased expression:liver: RGD PMID:22156924 RGD:15014782 NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366 		JBrowse link
lung metastasis term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ADAM28 ADAM metallopeptidase domain 28 ameliorates ISO associated with lung adenocarcinoma;
associated with lung carcinoma, breast carcinoma		 RGD PMID:22636800 PMID:26800504 RGD:11531771 RGD:153297785 NCBI chr14:8,375,169...8,438,622
Ensembl chr14:8,375,212...8,438,615 		JBrowse link
G ARHGAP5 Rho GTPase activating protein 5 ISO associated with Mammary Neoplasms, Experimental RGD PMID:20860838 RGD:126848767 NCBI chr 7:67,494,237...67,631,461
Ensembl chr 7:67,494,941...67,594,197 		JBrowse link
G ARID2 AT-rich interaction domain 2 exacerbates ISO associated with hepatocellular carcinoma, RGD PMID:32071245 RGD:150340708 NCBI chr 5:76,637,385...76,800,155
Ensembl chr 5:76,636,967...76,797,043 		JBrowse link
G AZGP1 alpha-2-glycoprotein 1, zinc-binding ameliorates ISO associated with hepatocellular carcinoma; RGD PMID:26902423 PMID:27993894 RGD:153350132 RGD:153350133 NCBI chr 3:7,867,521...7,874,857 JBrowse link
G CA12 carbonic anhydrase 12 ameliorates ISO associated with breast cancer; RGD PMID:29786141 RGD:155226861 NCBI chr 1:108,649,277...108,710,658
Ensembl chr 1:108,649,271...108,710,651 		JBrowse link
G CBLB Cbl proto-oncogene B severity ISO associated with stomach carcinoma; RGD PMID:28334634 RGD:150540337 NCBI chr13:153,480,525...153,700,115
Ensembl chr13:153,395,978...153,700,056 		JBrowse link
G CCNG1 cyclin G1 ISO RGD PMID:30565428 RGD:151361205 NCBI chr16:60,349,255...60,356,737
Ensembl chr16:60,349,258...60,356,738 		JBrowse link
G CHD4 chromodomain helicase DNA binding protein 4 ameliorates ISO associated with human colon adenocarcinoma cells in a mouse model RGD PMID:28486105 RGD:153323299 NCBI chr 5:64,071,627...64,105,212
Ensembl chr 5:64,065,992...64,105,173 		JBrowse link
G COL10A1 collagen type X alpha 1 chain ameliorates ISO associated with H1299 cell RGD PMID:33324550 RGD:150429752 NCBI chr 1:81,766,829...81,773,818
Ensembl chr 1:81,765,859...81,773,818 		JBrowse link
G CXCR4 C-X-C motif chemokine receptor 4 ameliorates ISO associated with colorectal cancer; human cells in mouse model
associated with nasopharynx carcinoma; human cells in mouse model
associated with osteosarcoma and melanoma		 RGD PMID:16000558 PMID:18071913 PMID:26498029 PMID:31938138 RGD:151665329 RGD:151893515 RGD:152023752 RGD:152177473 NCBI chr15:15,663,652...15,666,706
Ensembl chr15:15,663,494...15,667,232 		JBrowse link
G DDR1 discoidin domain receptor tyrosine kinase 1 ISO RGD PMID:29483153 RGD:151347599 NCBI chr 7:23,371,358...23,391,585
Ensembl chr 7:23,373,845...23,391,584 		JBrowse link
G DDR2 discoidin domain receptor tyrosine kinase 2 exacerbates ISO associated with tongue squamous cell carcinoma; RGD PMID:24556606 RGD:150429746 NCBI chr 4:87,749,738...87,911,818
Ensembl chr 4:87,756,168...87,911,296 		JBrowse link
G FASN fatty acid synthase ISO associated with head and neck squamous cell carcinoma RGD PMID:20604875 RGD:126790467 NCBI chr12:922,405...937,560
Ensembl chr12:920,509...937,561 		JBrowse link
G FOSL2 FOS like 2, AP-1 transcription factor subunit ISO human cells in mouse model RGD PMID:30326930 RGD:153344557 NCBI chr 3:110,820,403...110,842,903
Ensembl chr 3:110,823,666...110,843,068 		JBrowse link
G HILPDA hypoxia inducible lipid droplet associated ISO human cells in mouse model RGD PMID:31142329 RGD:153344574 NCBI chr18:19,944,929...19,947,080
Ensembl chr18:19,944,930...19,947,080 		JBrowse link
G IQSEC1 IQ motif and Sec7 domain ArfGEF 1 ISO human cells in mouse model RGD PMID:18084281 RGD:153344604 NCBI chr13:71,203,967...71,366,685
Ensembl chr13:71,031,001...71,366,684 		JBrowse link
G ITGAV integrin subunit alpha V treatment ISO human cells in rat model RGD PMID:20841470 RGD:152998949 NCBI chr15:91,604,666...91,711,843
Ensembl chr15:91,604,676...91,711,851 		JBrowse link
G MAP3K1 mitogen-activated protein kinase kinase kinase 1 ameliorates ISO associated with breast carcinoma RGD PMID:16568086 RGD:150573808 NCBI chr16:35,872,301...35,947,097
Ensembl chr16:35,872,131...35,946,987 		JBrowse link
G MAP3K8 mitogen-activated protein kinase kinase kinase 8 ameliorates ISO associated with clear cell renal cell carcinoma RGD PMID:23982215 RGD:151356974 NCBI chr10:40,714,004...40,746,390
Ensembl chr10:40,713,847...40,742,462 		JBrowse link
G MIR423 microRNA mir-423 ISO human cells in mouse model RGD PMID:30326930 RGD:153344557 NCBI chr12:46,211,525...46,211,604
Ensembl chr12:46,211,525...46,211,611 		JBrowse link
G MIR744 microRNA mir-744 treatment ISO associated with nasopharynx carcinoma RGD PMID:25961434 RGD:11056278 NCBI chr12:56,464,848...56,464,927
Ensembl chr12:56,464,848...56,464,927 		JBrowse link
G NF2 NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor ISO associated with hepatocellular carcinoma RGD PMID:26443326 RGD:11076529 NCBI chr14:46,653,869...46,726,421
Ensembl chr14:46,653,900...46,731,999 		JBrowse link
G NTRK3 neurotrophic receptor tyrosine kinase 3 ameliorates ISO associated with mammary carcinoma RGD PMID:20802235 RGD:150520014 NCBI chr 1:191,535,262...191,941,675
Ensembl chr 1:191,535,301...191,925,327 		JBrowse link
G PAGR1 PAXIP1 associated glutamate rich protein 1 ISO human cells in mouse model RGD PMID:33833989 RGD:153344568 NCBI chr 3:18,052,679...18,056,920
Ensembl chr 3:18,052,935...18,056,837 		JBrowse link
G PTPRB protein tyrosine phosphatase receptor type B treatment ISO RGD PMID:23899555 RGD:151660352 NCBI chr 5:34,656,460...34,794,838
Ensembl chr 5:34,659,964...34,794,289 		JBrowse link
G RICTOR RPTOR independent companion of MTOR complex 2 ISO human cells in mouse model RGD PMID:20978191 PMID:29809146 RGD:152995469 RGD:152995516 NCBI chr16:24,109,934...24,250,019
Ensembl chr16:24,109,939...24,311,132 		JBrowse link
G RPTOR regulatory associated protein of MTOR complex 1 ISO RGD PMID:29809146 RGD:152995516 NCBI chr12:1,709,121...1,991,844
Ensembl chr12:1,709,128...1,991,574 		JBrowse link
G SF3B4 splicing factor 3b subunit 4 ISO human cells in mouse model RGD PMID:30391496 RGD:155804298 NCBI chr 4:99,123,564...99,129,218
Ensembl chr 4:99,123,585...99,129,218 		JBrowse link
G SOX30 SRY-box transcription factor 30 ameliorates ISO RGD PMID:29739711 RGD:151660333 NCBI chr16:65,642,107...65,677,693
Ensembl chr16:65,642,223...65,678,047 		JBrowse link
G SRC SRC proto-oncogene, non-receptor tyrosine kinase treatment
ameliorates		 ISO associated with breast cancer;
associated with nasopharynx carcinoma;		 RGD PMID:15753384 PMID:27078847 RGD:150521726 RGD:1581400 NCBI chr17:40,470,970...40,524,862
Ensembl chr17:40,471,009...40,524,860 		JBrowse link
Lymphatic Metastasis term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ADAM28 ADAM metallopeptidase domain 28 ISO associated with breast cancer;DNA:hypermethylation: RGD PMID:25620615 RGD:153298970 NCBI chr14:8,375,169...8,438,622
Ensembl chr14:8,375,212...8,438,615 		JBrowse link
G ADGRB1 adhesion G protein-coupled receptor B1 disease_progression ISO associated with stomach cancer; RGD PMID:11172604 RGD:13831357 NCBI chr 4:1,582,321...1,658,639
Ensembl chr 4:1,582,330...1,647,573 		JBrowse link
G AICDA activation induced cytidine deaminase ISO associated with stomach cancer;protein:increased expression:stomach (human) RGD PMID:21538122 RGD:127285638 NCBI chr 5:62,777,236...62,787,342
Ensembl chr 5:62,777,352...62,787,369 		JBrowse link
G ANGPTL4 angiopoietin like 4 ISO CTD Direct Evidence: therapeutic CTD PMID:17130448 NCBI chr 2:70,905,767...70,912,892
Ensembl chr 2:70,904,531...70,912,974 		JBrowse link
G ANXA1 annexin A1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19381893 NCBI chr 1:226,414,200...226,431,963
Ensembl chr 1:226,414,306...226,432,279 		JBrowse link
G AQP3 aquaporin 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21401805 NCBI chr10:33,045,374...33,050,285
Ensembl chr10:33,045,245...33,051,082 		JBrowse link
G ARHGAP5 Rho GTPase activating protein 5 ISO associated with nasopharynx carcinoma;mRNA, protein:increased expression: epithelium of nasopharynx RGD PMID:25961434 RGD:11056278 NCBI chr 7:67,494,237...67,631,461
Ensembl chr 7:67,494,941...67,594,197 		JBrowse link
G ASXL1 ASXL transcriptional regulator 1 ISO associated with colorectal cancer RGD PMID:32317519 RGD:126779580 NCBI chr17:35,985,978...36,067,122
Ensembl chr17:35,985,535...36,067,119 		JBrowse link
G AXL AXL receptor tyrosine kinase ISO associated Pancreatic Neoplasms RGD PMID:19252414 RGD:2325833 NCBI chr 6:49,245,802...49,277,917
Ensembl chr 6:49,245,673...49,277,914 		JBrowse link
G BAG1 BAG cochaperone 1 disease_progression ISO associated with Breast Neoplasms:protein:increased expression:breast RGD PMID:18430249 RGD:2292908 NCBI chr10:33,227,530...33,240,731
Ensembl chr10:33,227,338...33,240,724 		JBrowse link
G BAMBI BMP and activin membrane bound inhibitor ISO associated with stomach cancer; protein:increased expression: : RGD PMID:24752577 RGD:14390158 NCBI chr10:40,053,368...40,058,590
Ensembl chr10:40,053,355...40,060,319 		JBrowse link
G BARHL2 BarH like homeobox 2 ISO associated with oral squamous cell carcinoma; mRNA:decreased expression:mouth mucosa RGD PMID:27542258 RGD:14390167 NCBI chr 4:126,030,373...126,035,662
Ensembl chr 4:126,029,437...126,036,210 		JBrowse link
G BCL2 BCL2 apoptosis regulator ISO associated with Breast Neoplasms;protein:increased expression:lymph node RGD PMID:18217456 RGD:2293013 NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879 		JBrowse link
G BIRC5 baculoviral IAP repeat containing 5 disease_progression ISO associated with Breast Neoplasms
associated with Cervix Neoplasms;mRNA:splice variant		 RGD PMID:17285241 PMID:17877643 RGD:2293098 RGD:2293103 NCBI chr12:3,747,276...3,755,214
Ensembl chr12:3,747,279...3,755,215 		JBrowse link
G BRAF B-Raf proto-oncogene, serine/threonine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:29426936 NCBI chr18:8,957,963...9,132,558
Ensembl chr18:8,957,991...9,132,553 		JBrowse link
G BRD7 bromodomain containing 7 severity ISO protein:increased expression:lung: RGD PMID:22008115 RGD:9586442 NCBI chr 6:34,478,008...34,519,622
Ensembl chr 6:34,478,012...34,519,663 		JBrowse link
G BSG basigin disease_progression ISO associated with Breast Neoplasms RGD PMID:16004819 RGD:2289055 NCBI chr 2:77,735,586...77,743,451 JBrowse link
G BTK Bruton tyrosine kinase disease_progression ISO associated with lung adenocarcinoma;protein:increased expression:lung (human) RGD PMID:31200752 RGD:151347847 NCBI chr  X:82,981,512...83,014,475
Ensembl chr  X:82,981,515...83,014,573 		JBrowse link
G CA9 carbonic anhydrase 9 ISO associated with Cervix Neoplasms RGD PMID:17233814 RGD:2293196 NCBI chr 1:236,393,727...236,400,994
Ensembl chr 1:236,394,306...236,400,822 		JBrowse link
G CAB39 calcium binding protein 39 ISO associated with pancreatic cancer;RNA:increased expression:pancreas RGD PMID:28197410 RGD:14398834 NCBI chr15:131,492,575...131,584,963
Ensembl chr15:131,492,578...131,584,962 		JBrowse link
G CASP9 caspase 9 ISO associated with Carcinoma, Non-Small-Cell Lung;DNA:SNP:exon:rs1052576 (human) RGD PMID:17285546 RGD:13434907 NCBI chr 6:74,707,597...74,730,033
Ensembl chr 6:74,706,516...74,730,007 		JBrowse link
G CAV1 caveolin 1 disease_progression ISO associated with Melanoma RGD PMID:22134245 RGD:8661767 NCBI chr18:29,648,120...29,682,451
Ensembl chr18:29,649,992...29,682,465 		JBrowse link
G CBL Cbl proto-oncogene ISO associated with stomach carcinoma;protein:increased expression:stomach RGD PMID:31611438 RGD:126925223 NCBI chr 9:46,416,937...46,512,855
Ensembl chr 9:46,416,938...46,512,834 		JBrowse link
G CBLB Cbl proto-oncogene B ISO associated with stomach carcinoma; RGD PMID:20038312 RGD:150540338 NCBI chr13:153,480,525...153,700,115
Ensembl chr13:153,395,978...153,700,056 		JBrowse link
G CCND2 cyclin D2 ISO associated with colorectal cancer;protein:increased expression:colorectum RGD PMID:19508551 RGD:151665111 NCBI chr 5:66,092,483...66,114,575
Ensembl chr 5:66,087,379...66,114,571 		JBrowse link
G CCNE1 cyclin E1 ISO associated with Carcinoma, Transitional Cell;protein:decreased expression RGD PMID:16949911 RGD:2289266 NCBI chr 6:39,919,541...39,933,224
Ensembl chr 6:39,919,624...39,933,363 		JBrowse link
G CCNH cyclin H ISO CTD Direct Evidence: marker/mechanism CTD PMID:30705370 NCBI chr 2:94,980,938...95,019,053
Ensembl chr 2:94,980,941...95,018,634 		JBrowse link
G CCR5 C-C motif chemokine receptor 5 ISO associated with Breast Neoplasms;mRNA:increased expression:lymph node RGD PMID:24301790 RGD:8551816 NCBI chr13:29,382,383...29,387,902
Ensembl chr13:29,383,303...29,387,895 		JBrowse link
G CD274 CD274 molecule ISO CTD Direct Evidence: marker/mechanism CTD PMID:16530813 NCBI chr 1:216,646,378...216,792,731
Ensembl chr 1:216,660,041...216,792,724 		JBrowse link
G CD40 CD40 molecule ISO associated with breast cancer;DNA:snps:5' utr, intron:c.-1T>C, c.51+914T>G (rs1883832, rs4810485) (human) RGD PMID:21912605 RGD:8547780 NCBI chr17:48,286,116...48,298,188
Ensembl chr17:48,286,029...48,298,528 		JBrowse link
G CD44 CD44 molecule ISO associated with Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms;mRNA, protein:splice variant, increased expression:breast, large intestine, stomach RGD PMID:16425351 RGD:2289356 NCBI chr 2:25,788,699...25,884,209
Ensembl chr 2:25,788,703...25,884,153 		JBrowse link
G CDH1 cadherin 1 ISO associated with Cervix Neoplasms
associated with Breast Neoplasms		 RGD PMID:17649807 PMID:18097581 RGD:2289498 RGD:2296046 NCBI chr 6:18,075,487...18,155,986
Ensembl chr 6:18,075,480...18,155,986 		JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A ISO associated with Oral Squamous Cell Carcinoma;
associated with Eyelid Neoplasms;		 RGD PMID:15817070 PMID:19628749 RGD:8661799 RGD:8662374 NCBI chr 7:32,354,776...32,363,771
Ensembl chr 7:32,359,455...32,363,761 		JBrowse link
G CDKN1B cyclin dependent kinase inhibitor 1B ISO associated with non-small cell lung carcinoma
associated with Breast Neoplasms		 RGD PMID:12015771 PMID:28601655 RGD:13673921 RGD:2293607 NCBI chr 5:59,731,224...59,735,831
Ensembl chr 5:59,731,206...59,735,831 		JBrowse link
G CDKN2A cyclin dependent kinase inhibitor 2A ISO CTD Direct Evidence: marker/mechanism CTD PMID:29426936 NCBI chr 1:200,774,496...200,799,149
Ensembl chr 1:200,792,469...200,798,854 		JBrowse link
G CLDN1 claudin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:33665778 NCBI chr13:127,714,857...127,730,628
Ensembl chr13:127,712,777...127,730,657 		JBrowse link
G CLPTM1L CLPTM1 like ISO associated with esophagus squamous cell carcinoma; mRNA:increased expression:esophagus RGD PMID:25480402 RGD:150530497 NCBI chr16:79,237,000...79,248,503
Ensembl chr16:79,237,061...79,248,500 		JBrowse link
G CLU clusterin ISO associated with breast cancer;DNA:snp:promoter:g.27611345C>G (rs9331888) (human) RGD PMID:22037783 RGD:8963167 NCBI chr14:11,336,585...11,352,569
Ensembl chr14:11,336,595...11,349,764 		JBrowse link
G COMT catechol-O-methyltransferase ISO associated with breast cancer;DNA:missense mutation:cds:p.V108/158M (human) RGD PMID:10755383 RGD:8662330 NCBI chr14:51,384,729...51,403,997
Ensembl chr14:51,385,738...51,403,998 		JBrowse link
G CRADD CASP2 and RIPK1 domain containing adaptor with death domain ISO associated with Prostatic Neoplasms RGD PMID:16707422 RGD:2298925 NCBI chr 5:89,257,603...89,480,414
Ensembl chr 5:89,267,944...89,479,712 		JBrowse link
G CRP C-reactive protein, pentraxin-related susceptibility ISO associated with Breast Neoplasm; DNA:polymorphism: :1846C>T(rs1205)(human) RGD PMID:24633920 RGD:9580226 NCBI chr 4:90,793,361...90,801,020
Ensembl chr 4:90,793,350...90,805,218 		JBrowse link
G CSF1R colony stimulating factor 1 receptor ISO associated with Breast Neoplasms RGD PMID:14734466 RGD:2293711 NCBI chr 2:151,102,138...151,130,311
Ensembl chr 2:151,102,147...151,147,633 		JBrowse link
G CTLA4 cytotoxic T-lymphocyte associated protein 4 ISO associated with Prostatic Neoplasms RGD PMID:10611340 RGD:4891523 NCBI chr15:107,283,081...107,288,041
Ensembl chr15:107,282,927...107,289,103 		JBrowse link
G CTNNA1 catenin alpha 1 ISO associated with Breast Neoplasms RGD PMID:12047765 RGD:2289795 NCBI chr 2:140,682,776...140,869,828
Ensembl chr 2:140,682,371...140,871,334 		JBrowse link
G CTNNB1 catenin beta 1 ISO associated with Breast Neoplasms;protein:decreased expression RGD PMID:17908479 RGD:2289813 NCBI chr13:25,163,550...25,208,314
Ensembl chr13:25,164,277...25,208,311 		JBrowse link
G CXCL12 C-X-C motif chemokine ligand 12 disease_progression ISO associated with stomach cancer;mRNA:increased expression:stomach (human) RGD PMID:21633638 RGD:152023624 NCBI chr14:91,516,383...91,543,857
Ensembl chr14:91,516,431...91,552,752 		JBrowse link
G CXCR4 C-X-C motif chemokine receptor 4 ISO associated with nasopharynx carcinoma; protein:increased expression:lymph node (human) RGD PMID:16000558 RGD:151893515 NCBI chr15:15,663,652...15,666,706
Ensembl chr15:15,663,494...15,667,232 		JBrowse link
G CYCS cytochrome c, somatic ISO associated with non-small cell lung carcinoma; protein:decreased expression:serum RGD PMID:25578497 RGD:13792769 NCBI chr18:47,169,921...47,172,212
Ensembl chr18:47,169,866...47,173,866 		JBrowse link
G DDR1 discoidin domain receptor tyrosine kinase 1 severity ISO mRNA, protein:increased expression:mouth (human)
mRNA:increased expression:kidney, lymph nodes (human)		 RGD PMID:27020590 PMID:31253192 RGD:151347620 RGD:151347863 NCBI chr 7:23,371,358...23,391,585
Ensembl chr 7:23,373,845...23,391,584 		JBrowse link
G DDR2 discoidin domain receptor tyrosine kinase 2 disease_progression ISO associated with oral squamous cell carcinoma RGD PMID:29945346 RGD:150429700 NCBI chr 4:87,749,738...87,911,818
Ensembl chr 4:87,756,168...87,911,296 		JBrowse link
G DNMT3B DNA methyltransferase 3 beta ISO associated with Carcinoma, Pancreatic Ductal; RGD PMID:22919364 RGD:9589121 NCBI chr17:36,345,715...36,386,076
Ensembl chr17:36,345,816...36,386,072 		JBrowse link
G EBAG9 estrogen receptor binding site associated antigen 9 ISO associated with Breast Neoplasms;protein:increased expression:breast
associated with Prostatic Neoplasm;protein:increased expression:prostate gland, lymph node		 RGD PMID:12054692 PMID:12845666 PMID:17187007 RGD:2289847 RGD:2289856 RGD:2298489 NCBI chr 4:27,986,270...28,013,970
Ensembl chr 4:27,986,866...28,013,945 		JBrowse link
G EGFR epidermal growth factor receptor treatment ISO associated with Squamous Cell Carcinoma of the Tongue RGD PMID:19380367 RGD:8551769 NCBI chr 9:139,302,410...139,474,632
Ensembl chr 9:139,300,022...139,475,589 		JBrowse link
G EHMT2 euchromatic histone lysine methyltransferase 2 ISO associated with Esophageal Squamous Cell Carcinoma;
associated with Melanoma;		 RGD PMID:24658378 PMID:24805087 RGD:9590069 RGD:9590071 NCBI chr 7:23,977,683...23,992,673
Ensembl chr 7:23,977,683...23,993,478 		JBrowse link
G EPHA2 EPH receptor A2 ISO protein:increased expression:esophagus (human) RGD PMID:33833989 RGD:153344568 NCBI chr 6:75,251,465...75,279,364
Ensembl chr 6:75,251,467...75,279,314 		JBrowse link
G ERBB2 erb-b2 receptor tyrosine kinase 2 disease_progression ISO associated with Breast Neoplasms;DNA, protein:polymorphism, increased expression:serum:p.I655V
associated with lung adenocarcinoma; protein:increased expression:lung (human)
associated with Carcinoma, Transitional Cell;protein:increased expression:urinary bladder
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:18097576 PMID:18237248 PMID:21532492 PMID:21966491 RGD:153344600 RGD:2289925 RGD:2289926 NCBI chr12:22,591,621...22,621,384
Ensembl chr12:22,590,725...22,621,351 		JBrowse link
G ERBB3 erb-b2 receptor tyrosine kinase 3 ISO associated with Prostatic Neoplasms;protein:increased expression, altered localization:lymph node, nucleus
associated with head and neck squamous cell carcinoma		 RGD PMID:17634423 PMID:20604875 RGD:126790467 RGD:2289944 NCBI chr 5:21,474,218...21,495,040
Ensembl chr 5:21,474,475...21,495,038 		JBrowse link
G ERBB4 erb-b2 receptor tyrosine kinase 4 severity
disease_progression		 ISO associated with colorectal adenocarcinoma
associated with lung non-small cell carcinoma
associated with oral squamous cell carcinoma		 RGD PMID:16507107 PMID:21324275 PMID:27444519 RGD:126781762 RGD:126781766 RGD:126790471 NCBI chr15:113,966,573...115,096,984
Ensembl chr15:113,974,437...115,096,565 		JBrowse link
G FAS Fas cell surface death receptor susceptibility ISO associated with Cervix Neoplasms;DNA:polymorphism:promoter:-1377G>A RGD PMID:18068525 RGD:2298509 NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716 		JBrowse link
G FGF1 fibroblast growth factor 1 ISO associated with Cervix Neoplasms;mRNA:increased expression:lymph node RGD PMID:17242701 RGD:2290286 NCBI chr 2:144,133,846...144,241,345
Ensembl chr 2:144,133,392...144,241,323 		JBrowse link
G FGFR2 fibroblast growth factor receptor 2 ISO associated with breast cancer;DNA:snp:intron:c.109+7033T>A (rs1219648) (human) RGD PMID:20640597 RGD:7394846 NCBI chr14:131,183,095...131,285,001
Ensembl chr14:131,181,713...131,289,425 		JBrowse link
G FLT3 fms related receptor tyrosine kinase 3 disease_progression ISO associated with Prostatic Neoplasms RGD PMID:14566827 RGD:2302210 NCBI chr11:5,370,475...5,455,439
Ensembl chr11:5,370,496...5,455,358 		JBrowse link
G FOXA1 forkhead box A1 ISO associated with lung non-small cell carcinoma; mRNA:increased expression: : RGD PMID:29115441 RGD:151665751 NCBI chr 7:62,471,233...62,479,638
Ensembl chr 7:62,471,249...62,479,220 		JBrowse link
G FOXP1 forkhead box P1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25485836 NCBI chr13:52,346,844...52,974,358
Ensembl chr13:52,348,234...52,876,892 		JBrowse link
G GPX3 glutathione peroxidase 3 ISO associated with stomach carcinoma; DNA:hypermethylation:promoter RGD PMID:23071548 RGD:151665353 NCBI chr16:71,980,467...71,989,011
Ensembl chr16:71,980,475...71,989,026 		JBrowse link
G GRIK2 glutamate ionotropic receptor kainate type subunit 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30705370 NCBI chr 1:68,052,086...68,680,448
Ensembl chr 1:68,057,538...68,679,256 		JBrowse link
G HMGB1 high mobility group box 1 ISO associated with Adenocarcinoma, Colon RGD PMID:20616616 RGD:10402080 NCBI chr11:7,195,556...7,321,071 JBrowse link
G ICAM1 intercellular adhesion molecule 1 ISO associated with Breast Neoplasms RGD PMID:21590495 RGD:8547712 NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205 		JBrowse link
G IER2 immediate early response 2 ISO RGD PMID:22120713 RGD:153323322 NCBI chr 2:65,909,638...65,912,491
Ensembl chr 2:65,909,651...65,912,445 		JBrowse link
G IL13 interleukin 13 ISO associated with Melanoma, Cutaneous Malignant;mRNA:increased expression:lymph node RGD PMID:17545514 RGD:8549587 NCBI chr 2:134,972,099...134,976,672
Ensembl chr 2:134,972,623...134,975,093 		JBrowse link
G IL18 interleukin 18 ISO associated with Breast Neoplasms;protein:increased expression:serum RGD PMID:12902898 RGD:8655867 NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219 		JBrowse link
G ING4 inhibitor of growth family member 4 ISO CTD Direct Evidence: therapeutic CTD PMID:27806345 NCBI chr 5:64,027,789...64,036,671
Ensembl chr 5:64,027,855...64,036,773 		JBrowse link
G IQSEC1 IQ motif and Sec7 domain ArfGEF 1 disease_progression ISO associated with lung adenocarcinoma; protein:increased expression:lung (human) RGD PMID:21966491 RGD:153344600 NCBI chr13:71,203,967...71,366,685
Ensembl chr13:71,031,001...71,366,684 		JBrowse link
G ITGB1 integrin subunit beta 1 ISO associated with non-small cell lung carcinoma, RGD PMID:28537888 RGD:13792830 NCBI chr10:56,078,393...56,130,608
Ensembl chr10:56,078,396...56,173,326 		JBrowse link
G KCNJ12 potassium inwardly rectifying channel subfamily J member 12 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34755307 NCBI chr12:61,424,459...61,511,373
Ensembl chr12:61,506,577...61,507,870 		JBrowse link
G KDR kinase insert domain receptor treatment ISO associated with Squamous Cell Carcinoma of the Tongue RGD PMID:19380367 RGD:8551769 NCBI chr 8:41,809,116...41,856,379
Ensembl chr 8:41,809,122...41,856,336 		JBrowse link
G KLF7 KLF transcription factor 7 ISO CTD Direct Evidence: therapeutic CTD PMID:37734194 NCBI chr15:110,282,399...110,380,165
Ensembl chr15:110,286,463...110,379,305 		JBrowse link
G KMT2D lysine methyltransferase 2D ISO associated with stomach cancer RGD PMID:30177394 RGD:150521710 NCBI chr 5:15,049,827...15,091,622 JBrowse link
G LAMC2 laminin subunit gamma 2 ISO associated with lung squamous cell carcinoma; RGD PMID:23124251 RGD:13793371 NCBI chr 9:124,427,545...124,499,672
Ensembl chr 9:124,435,807...124,495,351 		JBrowse link
G LOC100514786 ATP-binding cassette sub-family A member 13 susceptibility ISO DNA:amplification:cds: (human, male) RGD PMID:27366209 RGD:152995256 NCBI chr 9:135,104,047...135,452,477
Ensembl chr 9:135,115,078...135,451,812 		JBrowse link
G LOC100524016 mesothelin ISO CTD Direct Evidence: marker/mechanism CTD PMID:22644300 NCBI chr 3:41,025,892...41,029,302 JBrowse link
G LOC100737875 solute carrier family 22 member 10-like ISO CTD Direct Evidence: marker/mechanism CTD PMID:30705370 NCBI chr 2:8,734,036...8,750,828 JBrowse link
G LRRC59 leucine rich repeat containing 59 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30705370 NCBI chr12:26,678,207...26,694,277
Ensembl chr12:26,677,226...26,694,279 		JBrowse link
G MACIR macrophage immunometabolism regulator ISO CTD Direct Evidence: marker/mechanism CTD PMID:30705370 NCBI chr 2:108,733,347...108,753,276
Ensembl chr 2:108,733,357...108,753,275 		JBrowse link
G MET MET proto-oncogene, receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:29426936 NCBI chr18:29,426,044...29,541,526
Ensembl chr18:29,426,048...29,541,512 		JBrowse link
G MIR125A microRNA mir-125a ISO associated with stomach cancer; RGD PMID:22322911 RGD:21408544 NCBI chr 6:58,331,566...58,331,645
Ensembl chr 6:58,331,566...58,331,645 		JBrowse link
G MIR152 microRNA mir-152 ISO associated with breast cancer RGD PMID:22935141 RGD:19165152 NCBI chr12:24,292,249...24,292,328
Ensembl chr12:24,292,251...24,292,336 		JBrowse link
G MIR155 microRNA mir-155 disease_progression ISO associated with colon cancer RGD PMID:26885061 PMID:27856635 PMID:29893326 RGD:21079444 RGD:21079446 RGD:21409756 NCBI chr13:189,138,822...189,138,902
Ensembl chr13:189,138,822...189,138,902 		JBrowse link
G MIR187 microRNA mir-187 ISO associated with oral squamous cell carcinoma; RNA:increased expression:plasma RGD PMID:27542258 RGD:14390167 NCBI chr 6:119,674,881...119,674,958 JBrowse link
G MIR224 microRNA mir-224 ISO associated with colorectal cancer; mRNA:decreased expression:colorectal mucosa: RGD PMID:25919696 RGD:14398749 NCBI chr  X:123,283,427...123,283,507
Ensembl chr  X:123,283,427...123,283,507 		JBrowse link
G MIR30A microRNA mir-30a ISO associated with Colorectal Neoplasms RGD PMID:23486085 RGD:13432035 NCBI chr 1:51,412,827...51,412,933
Ensembl chr 1:51,412,827...51,412,933 		JBrowse link
G MIR335 microRNA mir-335 ISO associated with stomach cancer; RNA:decreased expression:stomach RGD PMID:21822301 RGD:14394425 NCBI chr18:18,341,580...18,341,659
Ensembl chr18:18,341,568...18,341,659 		JBrowse link
G MIR432 microRNA mir-432 disease_progression ISO mRNA:decreased expression:colon (human) RGD PMID:33717244 RGD:152999433 NCBI chr 7:121,711,137...121,711,216
Ensembl chr 7:121,711,137...121,711,216 		JBrowse link
G MMP2 matrix metallopeptidase 2 disease_progression ISO associated with Tongue Neoplasms
associated with Carcinoma, Ductal, Breast		 RGD PMID:23107277 PMID:23280016 RGD:8547824 RGD:8655998 NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,595...30,086,982 		JBrowse link
G MMP3 matrix metallopeptidase 3 ISO associated with breast cancer;DNA:deletion:promoter:-1170_-1172delA (human) RGD PMID:15161710 RGD:8662937 NCBI chr 9:33,446,969...33,453,995
Ensembl chr 9:33,446,836...33,454,000 		JBrowse link
G MMP9 matrix metallopeptidase 9 disease_progression ISO associated with Tongue Neoplasms
associated with Endometrial Neoplasms;protein:increased expression:endometrium
associated with Carcinoma, Non-Small-Cell Lung;protein:increased expression:serum		 RGD PMID:12487935 PMID:20704821 PMID:23107277 RGD:2298523 RGD:5129215 RGD:8547824 NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788 		JBrowse link
G MSH2 mutS homolog 2 ISO associated with laryngeal squamous cell carcinoma RGD PMID:24459922 RGD:126848797 NCBI chr 3:93,082,958...93,163,556
Ensembl chr 3:93,081,219...93,163,585 		JBrowse link
G MT1A metallothionein 1A ISO CTD Direct Evidence: marker/mechanism CTD PMID:17418620 NCBI chr 6:18,672,016...18,673,673
Ensembl chr 6:18,672,001...18,673,672 		JBrowse link
G MTA1 metastasis associated 1 ISO associated with Carcinoma, Non-Small-Cell Lung;mRNA:increased expression:lung RGD PMID:11804687 RGD:9588220
G MTOR mechanistic target of rapamycin kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:30705370 NCBI chr 6:71,286,989...71,412,913
Ensembl chr 6:71,286,989...71,412,888 		JBrowse link
G MUC1 mucin 1, cell surface associated ISO associated with Esophageal Neoplasms
associated with Common Bile Duct Neoplasms
associated with Gallbladder Neoplasms;protein:altered localization:gallbladder
associated with Carcinoma, Renal Cell;		 RGD PMID:10390012 PMID:11295067 PMID:16222735 PMID:21339746 RGD:2324649 RGD:2324860 RGD:7245968 RGD:7349383 NCBI chr 4:94,626,317...94,631,194 JBrowse link
G MUC5AC mucin 5AC, oligomeric mucus/gel-forming ISO associated with chloangiocarcinoma;protein:increased expression:bile duct RGD PMID:16842244 RGD:2325168 NCBI chr 2:757,897...790,321 JBrowse link
G NCAM1 neural cell adhesion molecule 1 ISO RGD PMID:10086383 RGD:2326067 NCBI chr 9:40,628,602...40,960,605
Ensembl chr 9:40,628,631...40,960,591 		JBrowse link
G NME1 NME/NM23 nucleoside diphosphate kinase 1 ISO associated with Breast Neoplasms
associated with Cervix Neoplasms; associated with Endometrial Neoplasms		 RGD PMID:8102131 PMID:8855975 PMID:9036878 RGD:2299061 RGD:2299062 RGD:2299077 NCBI chr12:27,416,308...27,435,044
Ensembl chr12:27,416,346...27,436,140 		JBrowse link
G NME2 NME/NM23 nucleoside diphosphate kinase 2 ISO associated with Cervix Neoplasms; associated with Endometrial Neoplasms RGD PMID:8855975 RGD:2299062 NCBI chr12:27,439,529...27,445,025
Ensembl chr12:27,439,260...27,445,027 		JBrowse link
G NOS3 nitric oxide synthase 3 susceptibility ISO associated with Breast Neoplasms;DNA:polymorphisms:promoter, exon:-786T>C,p.E298D (human) RGD PMID:17262178 RGD:2292070 NCBI chr18:6,209,218...6,228,912
Ensembl chr18:6,209,158...6,228,943 		JBrowse link
G OGG1 8-oxoguanine DNA glycosylase ISO associated with breast cancer;DNA:missense mutation:cds:p.S326C (rs1052133) (human) RGD PMID:18977234 RGD:8657156 NCBI chr13:66,038,669...66,045,478 JBrowse link
G PAGR1 PAXIP1 associated glutamate rich protein 1 disease_progression ISO protein:decreased expression:esophagus (human) RGD PMID:33833989 RGD:153344568 NCBI chr 3:18,052,679...18,056,920
Ensembl chr 3:18,052,935...18,056,837 		JBrowse link
G PDGFA platelet derived growth factor subunit A ISO associated with Breast Neoplasms;mRNA:increased expression:breast RGD PMID:8619189 RGD:2292155 NCBI chr 3:296,399...322,967
Ensembl chr 3:301,584...321,712 		JBrowse link
G PDGFB platelet derived growth factor subunit B ISO associated with Breast Neoplasms;mRNA:increased expression:lymph node RGD PMID:17674348 RGD:2292173 Ensembl chr 5:8,986,462...9,007,435 JBrowse link
G PDPK1 3-phosphoinositide dependent protein kinase 1 ISO associated with non-small cell lung carcinoma;mRNA:increased expression:blood serum RGD PMID:25064732 RGD:13503320 NCBI chr 3:39,429,928...39,512,623
Ensembl chr 3:39,432,058...39,512,601 		JBrowse link
G PDPN podoplanin ISO associated with Breast Neoplasms
associated with Cervix Neoplasms		 RGD PMID:16528371 PMID:18165897 RGD:2292231 RGD:2292237 NCBI chr 6:73,019,063...73,050,000
Ensembl chr 6:73,019,057...73,049,996 		JBrowse link
G PEBP1 phosphatidylethanolamine binding protein 1 ISO associated with Cervix Neoplasms
associated with Breast Neoplasms		 RGD PMID:16243812 PMID:18191186 RGD:2302867 RGD:2302868 NCBI chr14:34,523,901...34,530,238 JBrowse link
G PIK3CA phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha ISO associated with Colorectal Neoplasms RGD PMID:25550888 RGD:13432030 NCBI chr13:117,193,935...117,282,151
Ensembl chr13:117,180,544...117,274,587 		JBrowse link
G PIK3CB phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta ISO associated with Colorectal Neoplasms RGD PMID:25550888 RGD:13432030 NCBI chr13:79,427,033...79,610,840
Ensembl chr13:79,425,835...79,610,840 		JBrowse link
G PIP5K1A phosphatidylinositol-4-phosphate 5-kinase type 1 alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:34755307 NCBI chr 4:98,012,941...98,062,166
Ensembl chr 4:98,012,945...98,056,815 		JBrowse link
G POU5F1 POU class 5 homeobox 1 ISO associated with Seminoma; associated with Carcinoma, Embryonal RGD PMID:15386301 RGD:2292442 NCBI chr 7:23,564,654...23,570,691 JBrowse link
G PPARG peroxisome proliferator activated receptor gamma ISO associated with Cholangiocarcinoma;protein:increased expression:bile duct epithelium RGD PMID:20021832 RGD:2317459 NCBI chr13:68,301,566...68,433,951
Ensembl chr13:68,302,322...68,433,944 		JBrowse link
G PREX1 phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 ISO associated with Prostatic Neoplasms RGD PMID:19305425 RGD:2314605 NCBI chr17:50,352,273...50,550,402
Ensembl chr17:50,354,775...50,550,637 		JBrowse link
G PTEN phosphatase and tensin homolog ISO associated with Breast Neoplasms
associated with Prostatic Neoplasms;protein:decreased expression:prostate		 RGD PMID:17163422 PMID:17919877 RGD:2292499 RGD:2292507 NCBI chr14:99,929,590...100,021,619 JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 ISO associated with Biliary Tract Neoplasms
associated with Breast Neoplasms
associated with carcinoma, non-small-cell lung; DNA:SNP: :929G>C(human)		 RGD PMID:18159174 PMID:18353210 PMID:20016751 RGD:2300128 RGD:2317165 RGD:5135471 NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884 		JBrowse link
G PTK2 protein tyrosine kinase 2 ISO associated with lung squamous cell carcinoma; protein:increased tyrosine phosphorylation:lymph node RGD PMID:23906871 RGD:152176664 NCBI chr 4:2,656,606...2,896,060
Ensembl chr 4:2,656,614...2,896,054 		JBrowse link
G PTPN13 protein tyrosine phosphatase non-receptor type 13 ISO associated with lung squamous cell carcinoma; protein:decreased expression:lymph node RGD PMID:23906871 RGD:152176664 NCBI chr 8:132,035,170...132,200,425
Ensembl chr 8:132,035,151...132,249,411 		JBrowse link
G RAMP2 receptor activity modifying protein 2 disease_progression ISO associated with colorectal cancer; protein:increased expression:lymph node (human) RGD PMID:23634287 RGD:151708733 NCBI chr12:20,092,204...20,094,426
Ensembl chr12:20,092,196...20,094,469 		JBrowse link
G RAMP3 receptor activity modifying protein 3 ISO associated with colorectal cancer; protein:increased expression:lymph node (human) RGD PMID:23634287 RGD:151708733 NCBI chr18:50,319,795...50,366,757
Ensembl chr18:50,319,797...50,366,739 		JBrowse link
G RASSF2 Ras association domain family member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17013896 NCBI chr17:13,773,289...13,822,729
Ensembl chr17:13,773,292...13,822,206 		JBrowse link
G RBM10 RNA binding motif protein 10 ISO associated with lung adenocarcinoma;DNA:missense mutation:exon:p.R241C (c.763C>T) (human) RGD PMID:30405763 RGD:151356993 NCBI chr  X:41,773,232...41,803,656
Ensembl chr  X:41,773,232...41,803,653 		JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit ISO associated with Prostatic Neoplasms;protein:altered localization:nucleus, prostate gland RGD PMID:17020979 RGD:2298757 NCBI chr 2:6,594,869...6,602,684
Ensembl chr 2:6,593,969...6,603,469 		JBrowse link
G RET ret proto-oncogene ISO associated with Pancreatic Neoplasms RGD PMID:18652760 RGD:2324925 NCBI chr14:61,305,818...61,361,416
Ensembl chr14:61,305,841...61,361,412 		JBrowse link
G RHOA ras homolog family member A ISO associated with Bladder Neoplasms;protein:increased expression:lymph node
associated with colorectal cancer		 RGD PMID:12855641 PMID:17597401 RGD:13432052 RGD:2298872 NCBI chr13:31,918,484...31,991,207
Ensembl chr13:31,918,834...31,986,607 		JBrowse link
G RICTOR RPTOR independent companion of MTOR complex 2 ISO associated with breast ductal carcinoma; protein:increased expression:breast tumor, lymph node (human) RGD PMID:20978191 RGD:152995469 NCBI chr16:24,109,934...24,250,019
Ensembl chr16:24,109,939...24,311,132 		JBrowse link
G RUNX1 RUNX family transcription factor 1 ISO associated with Carcinoid Tumor RGD PMID:21636701 RGD:126779567 NCBI chr13:198,371,835...198,635,648
Ensembl chr13:198,371,837...198,638,189 		JBrowse link
G SFN stratifin ISO CTD Direct Evidence: marker/mechanism CTD PMID:19381893 NCBI chr 6:84,188,521...84,189,824
Ensembl chr 6:84,188,445...84,189,827 		JBrowse link
G SKP2 S-phase kinase associated protein 2 ISO associated with Endometrial Neoplasms;protein:increased expression:endometrium RGD PMID:16080017 RGD:2315043 NCBI chr16:21,463,270...21,500,925
Ensembl chr16:21,463,012...21,509,310 		JBrowse link
G SLC7A5 solute carrier family 7 member 5 severity ISO associated with gastric adenocarcinoma;protein:increased expression: :
associated with stomach carcinoma		 RGD PMID:21501294 PMID:25908107 RGD:11052781 RGD:151361203 NCBI chr 6:1,545,940...1,574,298
Ensembl chr 6:1,545,944...1,574,285 		JBrowse link
G SMAD4 SMAD family member 4 ISO associated with Breast Neoplasms RGD PMID:11809701 RGD:2300007 NCBI chr 1:100,521,843...100,633,501
Ensembl chr 1:100,589,850...100,628,029 		JBrowse link
G SMO smoothened, frizzled class receptor ISO associated with colorectal cancer RGD PMID:30784110 RGD:150520177 NCBI chr18:19,450,730...19,478,796
Ensembl chr18:19,450,743...19,478,898 		JBrowse link
G SNCG synuclein gamma ISO RGD PMID:15221989 RGD:6478801 NCBI chr14:87,916,353...87,922,111
Ensembl chr14:87,904,659...87,922,095 		JBrowse link
G SOCS3 suppressor of cytokine signaling 3 ISO associated with Breast Neoplasms RGD PMID:18097573 RGD:2298901 NCBI chr12:3,643,832...3,647,015
Ensembl chr12:3,643,929...3,647,009 		JBrowse link
G SOD2 superoxide dismutase 2 disease_progression ISO associated with tongue neoplasms;
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:10853026 PMID:19381893 PMID:20618948 RGD:8547519 NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,679,352...7,689,560 		JBrowse link
G SOX2 SRY-box transcription factor 2 disease_progression ISO associated with Breast Neoplasms RGD PMID:24382260 RGD:8661670 NCBI chr13:119,668,476...119,669,435
Ensembl chr13:119,668,476...119,669,435 		JBrowse link
G SRC SRC proto-oncogene, non-receptor tyrosine kinase ISO associated with colon adenocarcinoma, RGD PMID:21282564 RGD:150520218 NCBI chr17:40,470,970...40,524,862
Ensembl chr17:40,471,009...40,524,860 		JBrowse link
G ST14 ST14 transmembrane serine protease matriptase ISO associated with Endometrial Neoplasms RGD PMID:19443387 RGD:2315087 NCBI chr 9:56,888,246...56,929,771
Ensembl chr 9:56,888,246...56,929,767 		JBrowse link
G STAT3 signal transducer and activator of transcription 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21549414 NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992 		JBrowse link
G STK11 serine/threonine kinase 11 ISO associated with Breast Neoplasms;protein:decreased expression RGD PMID:12114407 RGD:2291948 NCBI chr 2:77,229,888...77,249,322
Ensembl chr 2:77,230,372...77,249,327 		JBrowse link
G TERT telomerase reverse transcriptase disease_progression ISO associated with lung non-small cell carcinoma; RGD PMID:11679180 RGD:152977755 NCBI chr16:79,258,591...79,276,421
Ensembl chr16:79,258,591...79,276,421 		JBrowse link
G TIMP1 TIMP metallopeptidase inhibitor 1 ISO associated with Endometrial Neoplasms;protein:increased expression:endometrium RGD PMID:12487935 RGD:2298523 NCBI chr  X:42,103,251...42,106,289
Ensembl chr  X:42,102,172...42,106,296 		JBrowse link
G TIMP3 TIMP metallopeptidase inhibitor 3 ISO associated with Breast Neoplasms;mRNA:increased expression:breast RGD PMID:12828172 RGD:2290437 NCBI chr 5:12,185,816...12,242,599
Ensembl chr 5:12,185,818...12,242,581 		JBrowse link
G TIMP4 TIMP metallopeptidase inhibitor 4 ISO associated with Breast Neoplasms;mRNA:increased expression:breast RGD PMID:12828172 RGD:2290437 NCBI chr13:68,179,803...68,191,199
Ensembl chr13:68,179,806...68,190,942 		JBrowse link
G TLR4 toll like receptor 4 ISO associated with Carcinoma, Ductal, Breast; RGD PMID:23338716 RGD:7794684 NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,058,970 		JBrowse link
G TP53 tumor protein p53 ISO associated with Penile Neoplasms
associated with Carcinoma, Squamous Cell;
associated with Breast Neoplasms;DNA:missense mutation, duplication:cds, intron:p.R72P		 RGD PMID:18059331 PMID:18230179 PMID:18268397 RGD:2290533 RGD:2290534 RGD:8547790 NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818 		JBrowse link
G TP53BP1 tumor protein p53 binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30705370 NCBI chr 1:127,958,500...128,032,370
Ensembl chr 1:127,959,213...128,028,712 		JBrowse link
G TRMT11 tRNA methyltransferase 11 homolog ISO CTD Direct Evidence: marker/mechanism CTD PMID:30705370 NCBI chr 1:36,930,857...37,002,079
Ensembl chr 1:36,940,334...37,002,056 		JBrowse link
G TSC2 TSC complex subunit 2 ISO associated with Breast Neoplasms RGD PMID:15951164 RGD:11568707 NCBI chr 3:39,898,924...39,935,579
Ensembl chr 3:39,898,925...39,937,371 		JBrowse link
G TSHR thyroid stimulating hormone receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:9062474 NCBI chr 7:103,768,260...103,925,777
Ensembl chr 7:103,768,296...103,925,922 		JBrowse link
G TTR transthyretin ISO associated with colorectal cancer;protein:decreased expresion:blood serum (human) RGD PMID:21074777 RGD:151665155 NCBI chr 6:115,496,338...115,503,974
Ensembl chr 6:115,496,326...115,503,977 		JBrowse link
G VEGFA vascular endothelial growth factor A ISO associated with Breast neoplasms;
associated with Cervix Neoplasms		 RGD PMID:17597103 PMID:19783962 RGD:2315454 RGD:7421574 NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366 		JBrowse link
G VEGFC vascular endothelial growth factor C exacerbates
disease_progression		 ISO associated with Prostatic Neoplasms
associated with pancreatic adenocarcinoma;protein:increased expression:pancreas (human)
associated with Lymphatic Metastasis;
associated with Breast Neoplasms
associated with thyroid diseases;mRNA:increased expression:thyroid gland:
associated with Carcinoma, Transitional Cell;protein:increased expression:urinary bladder
associated with Cervix Neoplasms		 RGD PMID:12203051 PMID:15289890 PMID:17034609 PMID:18061373 PMID:19589137 More... RGD:155630642 RGD:2315469 RGD:2315474 RGD:2315475 RGD:2315484 RGD:7483611 RGD:7488946 NCBI chr15:39,037,764...39,136,234
Ensembl chr15:39,039,311...39,132,936 		JBrowse link
G VEGFD vascular endothelial growth factor D ISO associated with Cervix Neoplasms
associated with Breast Neoplasms		 RGD PMID:17951197 PMID:19589137 RGD:2315475 RGD:2315480 NCBI chr  X:11,893,254...11,933,923
Ensembl chr  X:11,893,259...11,933,809 		JBrowse link
G WRAP53 WD repeat containing antisense to TP53 ISO associated with esophagus squamous cell carcinoma;
associated with lung non-small cell carcinoma;		 RGD PMID:24626331 PMID:31281482 RGD:21081513 RGD:21081532 NCBI chr12:52,954,674...52,968,371
Ensembl chr12:52,954,669...52,968,364 		JBrowse link
Neoplasm Invasiveness term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACO1 aconitase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20390345 NCBI chr10:33,937,833...34,001,895
Ensembl chr10:33,937,833...34,001,900 		JBrowse link
G ACTB actin beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:15654357 NCBI chr 3:4,084,275...4,090,383
Ensembl chr 3:4,082,216...4,090,356 		JBrowse link
G ADAMTS1 ADAM metallopeptidase with thrombospondin type 1 motif 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23289900 NCBI chr13:190,277,175...190,285,957
Ensembl chr13:190,276,430...190,286,214 		JBrowse link
G AHNAK AHNAK nucleoprotein ISO CTD Direct Evidence: marker/mechanism CTD PMID:20388789 NCBI chr 2:9,186,984...9,216,450 JBrowse link
G AHR aryl hydrocarbon receptor ISO CTD Direct Evidence: therapeutic CTD PMID:25826687 PMID:27752740 NCBI chr 9:86,511,866...86,555,950
Ensembl chr 9:86,511,369...86,555,943 		JBrowse link
G ALDOA aldolase, fructose-bisphosphate A ISO CTD Direct Evidence: marker/mechanism CTD PMID:15654357 NCBI chr 3:18,246,036...18,260,167
Ensembl chr 3:18,253,384...18,260,163 		JBrowse link
G ALKBH8 alkB homolog 8, tRNA methyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:27811057 NCBI chr 9:36,077,004...36,119,936
Ensembl chr 9:36,077,192...36,119,920 		JBrowse link
G ALOX5 arachidonate 5-lipoxygenase ISO CTD Direct Evidence: marker/mechanism CTD PMID:20061081 NCBI chr14:90,859,209...90,907,084
Ensembl chr14:90,859,016...90,907,094 		JBrowse link
G AMBP alpha-1-microglobulin/bikunin precursor ISO CTD Direct Evidence: therapeutic CTD PMID:14644129 NCBI chr 1:254,683,885...254,703,220
Ensembl chr 1:254,683,891...254,703,225 		JBrowse link
G AMOTL1 angiomotin like 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34480788 NCBI chr 9:26,811,872...26,978,107
Ensembl chr 9:26,864,312...26,973,552 		JBrowse link
G ANGPT1 angiopoietin 1 ISO associated with Mammary Neoplasms, Animal;mRNA:increased expression:mammary gland RGD PMID:15459484 RGD:1626167 NCBI chr 4:29,925,203...30,233,434
Ensembl chr 4:29,933,135...30,233,960 		JBrowse link
G ANGPTL4 angiopoietin like 4 ISO CTD Direct Evidence: therapeutic CTD PMID:17130448 NCBI chr 2:70,905,767...70,912,892
Ensembl chr 2:70,904,531...70,912,974 		JBrowse link
G ANXA1 annexin A1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15654357 NCBI chr 1:226,414,200...226,431,963
Ensembl chr 1:226,414,306...226,432,279 		JBrowse link
G ANXA2 annexin A2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15654357 NCBI chr 1:111,588,721...111,635,064
Ensembl chr 1:111,588,306...111,635,059 		JBrowse link
G ARF1 ADP ribosylation factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27517156 NCBI chr 2:51,219,597...51,237,640
Ensembl chr 2:51,219,667...51,237,639 		JBrowse link
G AXL AXL receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:26206560 NCBI chr 6:49,245,802...49,277,917
Ensembl chr 6:49,245,673...49,277,914 		JBrowse link
G BCAR1 BCAR1 scaffold protein, Cas family member ISO CTD Direct Evidence: marker/mechanism CTD PMID:21291860 NCBI chr 6:12,369,332...12,404,822
Ensembl chr 6:12,367,758...12,404,818 		JBrowse link
G BRMS1 BRMS1 transcriptional repressor and anoikis regulator ISO CTD Direct Evidence: therapeutic CTD PMID:27501413 NCBI chr 2:6,046,077...6,053,672
Ensembl chr 2:6,046,098...6,053,667 		JBrowse link
G BSG basigin ISO CTD Direct Evidence: marker/mechanism CTD PMID:21165561 NCBI chr 2:77,735,586...77,743,451 JBrowse link
G CALR calreticulin ISO CTD Direct Evidence: marker/mechanism CTD PMID:15048980 NCBI chr 2:66,098,263...66,102,074
Ensembl chr 2:66,098,229...66,102,132 		JBrowse link
G CALU calumenin ISO CTD Direct Evidence: marker/mechanism CTD PMID:15048980 NCBI chr18:19,841,718...19,875,804
Ensembl chr18:19,841,719...19,875,786 		JBrowse link
G CAT catalase ISO CTD Direct Evidence: therapeutic CTD PMID:21749277 PMID:22580338 NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452 		JBrowse link
G CCL2 chemokine (C-C motif) ligand 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25199511 PMID:32512068 NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026 		JBrowse link
G CCL3L1 chemokine (C-C motif) ligand 3-like 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:36346222 NCBI chr12:39,491,999...39,493,345
Ensembl chr12:39,491,914...39,493,774 		JBrowse link
G CCL5 C-C motif chemokine ligand 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18985009 NCBI chr12:39,652,731...39,659,121
Ensembl chr12:39,648,598...39,659,118 		JBrowse link
G CD82 CD82 molecule ISO CTD Direct Evidence: therapeutic CTD PMID:20075392 NCBI chr 2:17,751,153...17,803,172
Ensembl chr 2:17,750,660...17,803,126 		JBrowse link
G CDH1 cadherin 1 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:19839049 PMID:22580338 NCBI chr 6:18,075,487...18,155,986
Ensembl chr 6:18,075,480...18,155,986 		JBrowse link
G CDH2 cadherin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27811057 NCBI chr 6:112,396,713...112,629,073
Ensembl chr 6:112,396,721...112,628,432 		JBrowse link
G CDKN2A cyclin dependent kinase inhibitor 2A ISO CTD Direct Evidence: marker/mechanism CTD PMID:24495407 NCBI chr 1:200,774,496...200,799,149
Ensembl chr 1:200,792,469...200,798,854 		JBrowse link
G CFL1 cofilin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15048980 NCBI chr 2:6,471,558...6,475,019
Ensembl chr 2:6,469,254...6,475,035 		JBrowse link
G CHI3L1 chitinase 3 like 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21029458 NCBI chr 9:113,885,541...113,895,033
Ensembl chr 9:113,885,542...113,895,131 		JBrowse link
G CHRNA7 cholinergic receptor nicotinic alpha 7 subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:18844224 NCBI chr 1:142,803,697...142,937,124
Ensembl chr 1:142,803,701...142,937,123 		JBrowse link
G CSE1L chromosome segregation 1 like ISO CTD Direct Evidence: marker/mechanism CTD PMID:34022224 NCBI chr17:50,744,896...50,796,835
Ensembl chr17:50,744,910...50,797,548 		JBrowse link
G CSTB cystatin B ISO CTD Direct Evidence: marker/mechanism CTD PMID:19747051 PMID:22287159 NCBI chr13:206,706,060...206,710,598
Ensembl chr13:206,706,063...206,710,646 		JBrowse link
G CTBP2 C-terminal binding protein 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28414304 NCBI chr14:134,329,312...134,488,805
Ensembl chr14:134,329,941...134,487,755 		JBrowse link
G CTNNB1 catenin beta 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23707762 PMID:26990689 NCBI chr13:25,163,550...25,208,314
Ensembl chr13:25,164,277...25,208,311 		JBrowse link
G CTSB cathepsin B ISO CTD Direct Evidence: marker/mechanism CTD PMID:19700239 PMID:19747051 NCBI chr14:15,014,139...15,035,081
Ensembl chr14:15,011,711...15,033,877 		JBrowse link
G CTSD cathepsin D ISO CTD Direct Evidence: marker/mechanism CTD PMID:15048980 NCBI chr 2:1,188,548...1,197,642
Ensembl chr 2:1,188,549...1,197,643 		JBrowse link
G CTSS cathepsin S ISO CTD Direct Evidence: marker/mechanism CTD PMID:19700239 NCBI chr 4:98,415,273...98,442,952
Ensembl chr 4:98,417,883...98,442,950 		JBrowse link
G CTU2 cytosolic thiouridylase subunit 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27811057 NCBI chr 6:964,551...976,881
Ensembl chr 6:964,566...976,832 		JBrowse link
G CXCL12 C-X-C motif chemokine ligand 12 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19700239 PMID:25231984 PMID:25753200 NCBI chr14:91,516,383...91,543,857
Ensembl chr14:91,516,431...91,552,752 		JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:32512068 NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861 		JBrowse link
G CXCR4 C-X-C motif chemokine receptor 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25753200 NCBI chr15:15,663,652...15,666,706
Ensembl chr15:15,663,494...15,667,232 		JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26213588 NCBI chr14:141,690,737...141,703,078
Ensembl chr14:141,690,426...141,736,817 		JBrowse link
G DEK DEK proto-oncogene ISO CTD Direct Evidence: marker/mechanism CTD PMID:21291860 PMID:27811057 NCBI chr 7:13,901,562...13,935,477
Ensembl chr 7:13,872,775...13,935,173 		JBrowse link
G DLX4 distal-less homeobox 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26213588 NCBI chr12:26,155,520...26,161,310
Ensembl chr12:26,155,561...26,161,298 		JBrowse link
G DMD dystrophin ISO CTD Direct Evidence: marker/mechanism CTD PMID:24793134 NCBI chr  X:27,028,223...29,650,728
Ensembl chr  X:27,028,231...28,383,840 		JBrowse link
G DNMT1 DNA methyltransferase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28544374 NCBI chr 2:68,981,564...69,040,364
Ensembl chr 2:68,981,566...69,029,844 		JBrowse link
G EDNRB endothelin receptor type B ISO CTD Direct Evidence: marker/mechanism CTD PMID:26213588 NCBI chr11:50,073,300...50,102,879
Ensembl chr11:50,072,554...50,102,884 		JBrowse link
G EEF2 eukaryotic translation elongation factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21554491 NCBI chr 2:74,746,541...74,756,687
Ensembl chr 2:74,747,080...74,756,680 		JBrowse link
G EGF epidermal growth factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:15802018 PMID:22869556 PMID:23064031 PMID:24587105 PMID:27634460 NCBI chr 8:112,235,607...112,330,062
Ensembl chr 8:112,234,386...112,330,046 		JBrowse link
G EGFR epidermal growth factor receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:18844224 PMID:23867902 NCBI chr 9:139,302,410...139,474,632
Ensembl chr 9:139,300,022...139,475,589 		JBrowse link
G EIF4E eukaryotic translation initiation factor 4E ISO CTD Direct Evidence: marker/mechanism CTD PMID:20388789 NCBI chr 8:121,409,633...121,464,467
Ensembl chr 8:121,409,731...121,464,471 		JBrowse link
G ELP1 elongator acetyltransferase complex subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27811057 NCBI chr 1:249,905,550...249,980,570
Ensembl chr 1:249,905,351...249,981,641 		JBrowse link
G ELP3 elongator acetyltransferase complex subunit 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27811057 NCBI chr14:11,832,947...11,940,080
Ensembl chr14:11,832,962...11,940,070 		JBrowse link
G EN1 engrailed homeobox 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26213588 NCBI chr15:24,402,605...24,408,377
Ensembl chr15:24,402,370...24,407,692 		JBrowse link
G ENO1 enolase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15654357 NCBI chr 6:69,385,879...69,401,664
Ensembl chr 6:69,385,879...69,401,151 		JBrowse link
G EPAS1 endothelial PAS domain protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26735578 PMID:30090327 NCBI chr 3:94,167,759...94,253,662
Ensembl chr 3:94,165,816...94,254,079 		JBrowse link
G EPO erythropoietin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16699298 NCBI chr 3:8,620,508...8,622,936
Ensembl chr 3:8,620,508...8,622,936 		JBrowse link
G EPOR erythropoietin receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:16699298 NCBI chr 2:70,063,601...70,068,821
Ensembl chr 2:70,063,519...70,068,821 		JBrowse link
G EPS8 EGFR pathway substrate 8, signaling adaptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:19799886 NCBI chr 5:56,817,445...57,005,117
Ensembl chr 5:56,817,606...57,005,113 		JBrowse link
G ESR1 estrogen receptor 1 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:26990689 PMID:27366082 PMID:35044086 NCBI chr 1:14,217,032...14,604,906
Ensembl chr 1:14,217,036...14,493,363 		JBrowse link
G FAM83A family with sequence similarity 83 member A ISO CTD Direct Evidence: marker/mechanism CTD PMID:34931434 NCBI chr 4:16,169,697...16,186,015
Ensembl chr 4:16,169,708...16,184,941 		JBrowse link
G FGFR4 fibroblast growth factor receptor 4 ISO ClinVar Annotator: match by term: Cancer progression and tumor cell motility ClinVar PMID:11830541 PMID:25741868 PMID:26675719 PMID:33116287 NCBI chr 2:80,841,536...80,853,791
Ensembl chr 2:80,841,536...80,853,796 		JBrowse link
G FN1 fibronectin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24014025 NCBI chr15:117,658,158...117,737,145
Ensembl chr15:117,658,099...117,731,014 		JBrowse link
G FOXP1 forkhead box P1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25485836 NCBI chr13:52,346,844...52,974,358
Ensembl chr13:52,348,234...52,876,892 		JBrowse link
G FTH1 ferritin heavy chain 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20390345 NCBI chr 2:9,535,051...9,537,979 JBrowse link
G FTL ferritin light chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:20390345 NCBI chr 6:54,231,121...54,232,756
Ensembl chr 6:54,231,172...54,232,750 		JBrowse link
G GAB2 GRB2 associated binding protein 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21996746 NCBI chr 9:12,663,658...12,851,423
Ensembl chr 9:12,663,657...12,851,342 		JBrowse link
G HDAC3 histone deacetylase 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34973135 NCBI chr 2:143,273,188...143,287,421
Ensembl chr 2:143,273,192...143,287,399 		JBrowse link
G HGF hepatocyte growth factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:9932610 PMID:15654357 NCBI chr 9:98,437,771...98,513,573
Ensembl chr 9:98,438,143...98,513,564 		JBrowse link
G HIF1A hypoxia inducible factor 1 subunit alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:12811834 PMID:29501572 NCBI chr 1:190,625,436...190,673,926
Ensembl chr 1:190,625,244...190,674,845 		JBrowse link
G HMGA2 high mobility group AT-hook 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28830677 NCBI chr 5:30,188,521...30,329,635 JBrowse link
G HMGCS2 3-hydroxy-3-methylglutaryl-CoA synthase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27816970 NCBI chr 4:101,420,941...101,440,302
Ensembl chr 4:101,420,872...101,438,126 		JBrowse link
G HMOX1 heme oxygenase 1 ISO CTD Direct Evidence: therapeutic CTD PMID:24211270
G HOXB13 homeobox B13 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26213588 NCBI chr12:24,948,307...24,950,661
Ensembl chr12:24,947,687...24,950,714 		JBrowse link
G HOXB3 homeobox B3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34652879 NCBI chr12:24,803,119...24,827,557
Ensembl chr12:24,804,647...24,809,937 		JBrowse link
G HPSE heparanase ISO CTD Direct Evidence: marker/mechanism CTD PMID:22240343 NCBI chr 8:135,082,199...135,120,887
Ensembl chr 8:135,097,725...135,120,887 		JBrowse link
G HRAS HRas proto-oncogene, GTPase ISO CTD Direct Evidence: marker/mechanism CTD PMID:23877152 NCBI chr 2:299,662...302,539
Ensembl chr 2:299,660...302,501 		JBrowse link
G ID4 inhibitor of DNA binding 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14633621 NCBI chr 7:15,281,535...15,284,895
Ensembl chr 7:15,281,757...15,282,839 		JBrowse link
G IGF1 insulin like growth factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18398872 NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,033 		JBrowse link
G IL1RN interleukin 1 receptor antagonist ISO CTD Direct Evidence: therapeutic CTD PMID:27567548
G IL6 interleukin 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26101800 PMID:26284488 NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263 		JBrowse link
G INS insulin ISO CTD Direct Evidence: marker/mechanism CTD PMID:24587105 NCBI chr 2:1,496,842...1,498,052
Ensembl chr 2:1,496,842...1,497,841 		JBrowse link
G IREB2 iron responsive element binding protein 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20390345 NCBI chr 7:47,481,539...47,529,199
Ensembl chr 7:47,478,706...47,529,242 		JBrowse link
G ITGA5 integrin subunit alpha 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21224397 NCBI chr 5:19,587,361...19,610,580
Ensembl chr 5:19,586,746...19,610,362 		JBrowse link
G ITGB1 integrin subunit beta 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21224397 NCBI chr10:56,078,393...56,130,608
Ensembl chr10:56,078,396...56,173,326 		JBrowse link
G ITPK1 inositol-tetrakisphosphate 1-kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:26213588 NCBI chr 7:114,361,976...114,520,805
Ensembl chr 7:114,361,968...114,520,793 		JBrowse link
G KCND2 potassium voltage-gated channel subfamily D member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34418280 NCBI chr18:26,139,457...26,624,210
Ensembl chr18:26,139,457...26,623,233 		JBrowse link
G KDM1A lysine demethylase 1A ISO CTD Direct Evidence: marker/mechanism CTD PMID:22493729 NCBI chr 6:80,903,407...80,971,875
Ensembl chr 6:80,903,424...80,971,873 		JBrowse link
G KRT19 keratin 19 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15048980 NCBI chr12:21,115,453...21,119,115
Ensembl chr12:21,115,448...21,119,107 		JBrowse link
G KRT7 keratin 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19921857 NCBI chr 5:17,553,192...17,570,582
Ensembl chr 5:17,555,728...17,570,581 		JBrowse link
G LDHB lactate dehydrogenase B ISO CTD Direct Evidence: marker/mechanism CTD PMID:15048980 NCBI chr 5:51,810,932...51,831,218 JBrowse link
G LEF1 lymphoid enhancer binding factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27811057 NCBI chr 8:113,824,511...113,944,078
Ensembl chr 8:113,825,161...113,944,070 		JBrowse link
G LIN28A lin-28 homolog A ISO CTD Direct Evidence: marker/mechanism CTD PMID:26910839 NCBI chr 6:83,806,178...83,818,550
Ensembl chr 6:83,806,056...83,818,633 		JBrowse link
G LOC100513450 P antigen family member 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26213588 NCBI chr  X:43,489,559...43,496,654
Ensembl chr  X:43,446,109...43,494,094 		JBrowse link
G LOC100516084 cytoplasmic tRNA 2-thiolation protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27811057 NCBI chr 6:58,388,646...58,396,509 JBrowse link
G LOC110258578 interleukin-1 beta-like ISO CTD Direct Evidence: marker/mechanism CTD PMID:27567548
G LOXL2 lysyl oxidase like 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24014025 NCBI chr14:7,435,861...7,540,699
Ensembl chr14:7,435,867...7,540,704 		JBrowse link
G MAPK1 mitogen-activated protein kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22580338 NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513 		JBrowse link
G MAPK3 mitogen-activated protein kinase 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22580338 NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567 		JBrowse link
G MET MET proto-oncogene, receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:15654357 NCBI chr18:29,426,044...29,541,526
Ensembl chr18:29,426,048...29,541,512 		JBrowse link
G MIR155 microRNA mir-155 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28315615 NCBI chr13:189,138,822...189,138,902
Ensembl chr13:189,138,822...189,138,902 		JBrowse link
G MIR186 microRNA mir-186 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34291859 NCBI chr 6:141,943,328...141,943,409
Ensembl chr 6:141,943,328...141,943,409 		JBrowse link
G MIR191 microRNA mir-191 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29277653 NCBI chr13:31,655,484...31,655,563
Ensembl chr13:31,655,484...31,655,563 		JBrowse link
G MIR21 microRNA mir-21 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26101800 PMID:29501572 NCBI chr12:36,065,267...36,065,358
Ensembl chr12:36,065,267...36,065,358 		JBrowse link
G MIR217-1 microRNA mir-217-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25538231 NCBI chr 3:85,341,255...85,341,361
Ensembl chr 3:85,341,255...85,341,361 		JBrowse link
G MIR497 microRNA mir-497 ISO CTD Direct Evidence: marker/mechanism CTD PMID:35066776 NCBI chr12:52,422,329...52,422,408
Ensembl chr12:52,422,330...52,422,411 		JBrowse link
G MIR532 microRNA mir-532 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30639441 NCBI chr  X:43,705,258...43,705,337
Ensembl chr  X:43,705,258...43,705,337 		JBrowse link
G MIR708 microRNA mir-708 ISO CTD Direct Evidence: therapeutic CTD PMID:34652879 NCBI chr 9:13,780,171...13,780,250
Ensembl chr 9:13,780,171...13,780,250 		JBrowse link
G MIR874 microRNA mir-874 ISO CTD Direct Evidence: therapeutic CTD PMID:30004169 NCBI chr 2:139,660,118...139,660,201
Ensembl chr 2:139,660,118...139,660,201 		JBrowse link
G MMP1 matrix metallopeptidase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22580338 NCBI chr 9:33,411,738...33,420,205
Ensembl chr 9:33,411,065...33,420,076 		JBrowse link
G MMP14 matrix metallopeptidase 14 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24014025 NCBI chr 7:76,174,502...76,185,931
Ensembl chr 7:76,172,971...76,185,928 		JBrowse link
G MMP2 matrix metallopeptidase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18398872 PMID:19770485 PMID:22321834 PMID:23707804 PMID:34278709 NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,595...30,086,982 		JBrowse link
G MMP3 matrix metallopeptidase 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20188714 PMID:26284488 NCBI chr 9:33,446,969...33,453,995
Ensembl chr 9:33,446,836...33,454,000 		JBrowse link
G MMP9 matrix metallopeptidase 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19617202 PMID:19700239 PMID:20188714 PMID:21187089 PMID:22503731 More... NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788 		JBrowse link
G MT-2B metallothionein-2A ISO CTD Direct Evidence: marker/mechanism CTD PMID:21187089 NCBI chr 6:18,645,125...18,646,034
Ensembl chr 6:18,645,153...18,646,033 		JBrowse link
G MT3 metallothionein 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23794209 NCBI chr 6:18,634,735...18,636,134
Ensembl chr 6:18,634,261...18,636,131 		JBrowse link
G MTDH metadherin ISO CTD Direct Evidence: marker/mechanism CTD PMID:29315995 NCBI chr 4:39,052,895...39,113,380
Ensembl chr 4:39,051,537...39,113,385 		JBrowse link
G MYD88 MYD88 innate immune signal transduction adaptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:21473897 NCBI chr13:22,976,951...22,979,568
Ensembl chr13:22,966,137...22,983,109 		JBrowse link
G MYH9 myosin heavy chain 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28650484 NCBI chr 5:11,365,603...11,456,475
Ensembl chr 5:11,360,660...11,456,472 		JBrowse link
G MYLK myosin light chain kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:10232591 PMID:12970723 NCBI chr13:136,509,878...136,809,674
Ensembl chr13:136,509,755...136,809,668 		JBrowse link
G NCAM1 neural cell adhesion molecule 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19700239 NCBI chr 9:40,628,602...40,960,605
Ensembl chr 9:40,628,631...40,960,591 		JBrowse link
G NEK2 NIMA related kinase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28509438 NCBI chr 9:131,547,044...131,560,527
Ensembl chr 9:131,547,069...131,561,095 		JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:32682831 NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,656...83,146,183 		JBrowse link
G NME1 NME/NM23 nucleoside diphosphate kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15048980 NCBI chr12:27,416,308...27,435,044
Ensembl chr12:27,416,346...27,436,140 		JBrowse link
G NOTCH2 notch receptor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30670679 NCBI chr 4:100,951,522...101,152,348
Ensembl chr 4:100,981,636...101,150,195 		JBrowse link
G NRG1 neuregulin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19617202 NCBI chr15:52,625,550...53,688,003
Ensembl chr15:52,630,679...52,839,505 		JBrowse link
G NUAK1 NUAK family kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26213588 PMID:26873845 NCBI chr 5:14,089,584...14,177,584
Ensembl chr 5:14,102,006...14,177,584 		JBrowse link
G PAK1 p21 (RAC1) activated kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:35066776 NCBI chr 9:11,830,095...11,973,074
Ensembl chr 9:11,830,095...12,020,415 		JBrowse link
G PAX6 paired box 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26213588 NCBI chr 2:28,971,565...29,001,149
Ensembl chr 2:28,978,287...29,001,200 		JBrowse link
G PDCD4 programmed cell death 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23272133 NCBI chr14:121,271,824...121,334,767
Ensembl chr14:121,305,629...121,338,740 		JBrowse link
G PIP5K1A phosphatidylinositol-4-phosphate 5-kinase type 1 alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:34755307 NCBI chr 4:98,012,941...98,062,166
Ensembl chr 4:98,012,945...98,056,815 		JBrowse link
G PKM pyruvate kinase M1/2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15048980 PMID:15654357 NCBI chr 7:60,971,807...61,032,780
Ensembl chr 7:60,975,667...61,004,316
Ensembl chr 7:60,975,667...61,004,316 		JBrowse link
G PLAU plasminogen activator, urokinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:14644129 PMID:26284488 NCBI chr14:76,629,313...76,635,173
Ensembl chr14:76,629,299...76,635,172 		JBrowse link
G PLAUR plasminogen activator, urokinase receptor ISO CTD Direct Evidence: marker/mechanism RGD
CTD		 PMID:12198772 PMID:22261521 RGD:729319 NCBI chr 6:50,489,773...50,505,453
Ensembl chr 6:50,489,777...50,505,418 		JBrowse link
G PPP1R12B protein phosphatase 1 regulatory subunit 12B ISO CTD Direct Evidence: marker/mechanism CTD PMID:28650484 NCBI chr10:24,463,900...24,637,361
Ensembl chr10:24,465,041...24,637,358 		JBrowse link
G PRDX2 peroxiredoxin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23911960 NCBI chr 2:66,207,829...66,211,474
Ensembl chr 2:66,207,828...66,212,009 		JBrowse link
G PTEN phosphatase and tensin homolog ISO CTD Direct Evidence: therapeutic CTD PMID:21994956 NCBI chr14:99,929,590...100,021,619 JBrowse link
G PTK2 protein tyrosine kinase 2 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:12811834 PMID:25199511 NCBI chr 4:2,656,606...2,896,060
Ensembl chr 4:2,656,614...2,896,054 		JBrowse link
G RAB27A RAB27A, member RAS oncogene family ISO CTD Direct Evidence: marker/mechanism CTD PMID:34291859 NCBI chr 1:116,532,816...116,606,477
Ensembl chr 1:116,532,974...116,606,474 		JBrowse link
G RAB27B RAB27B, member RAS oncogene family ISO CTD Direct Evidence: marker/mechanism CTD PMID:34291859 NCBI chr 1:104,241,500...104,418,721
Ensembl chr 1:104,241,571...104,417,084 		JBrowse link
G RASAL2 RAS protein activator like 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34826200 NCBI chr 9:119,941,303...120,329,817
Ensembl chr 9:119,941,862...120,325,316 		JBrowse link
G RBM38 RNA binding motif protein 38 ISO CTD Direct Evidence: therapeutic CTD PMID:34453780 NCBI chr17:57,783,156...57,802,495
Ensembl chr17:57,783,154...57,797,990 		JBrowse link
G RECK reversion inducing cysteine rich protein with kazal motifs ISO CTD Direct Evidence: therapeutic CTD PMID:20127710 NCBI chr 1:236,821,243...236,898,280
Ensembl chr 1:236,821,414...236,898,276 		JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:19896475 PMID:29501572 NCBI chr 2:6,594,869...6,602,684
Ensembl chr 2:6,593,969...6,603,469 		JBrowse link
G RHOA ras homolog family member A ISO CTD Direct Evidence: marker/mechanism CTD PMID:19896475 NCBI chr13:31,918,484...31,991,207
Ensembl chr13:31,918,834...31,986,607 		JBrowse link
G RNF207 ring finger protein 207 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26213588 NCBI chr 6:67,105,347...67,119,167
Ensembl chr 6:67,106,552...67,116,510 		JBrowse link
G RPL3L ribosomal protein L3 like ISO CTD Direct Evidence: marker/mechanism CTD PMID:26213588 NCBI chr 3:40,004,907...40,016,702
Ensembl chr 3:40,007,868...40,016,699 		JBrowse link
G RPS6KA3 ribosomal protein S6 kinase A3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21488662 NCBI chr  X:16,452,401...16,576,854
Ensembl chr  X:16,452,405...16,576,859 		JBrowse link
G RPSA ribosomal protein SA ISO CTD Direct Evidence: marker/mechanism CTD PMID:15048980 NCBI chr13:24,072,551...24,081,536
Ensembl chr13:24,072,527...24,081,541 		JBrowse link
G S100A11 S100 calcium binding protein A11 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20388789 NCBI chr 4:97,233,833...97,239,081
Ensembl chr 4:97,233,811...97,243,423 		JBrowse link
G S100A4 S100 calcium binding protein A4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15048980 NCBI chr 4:96,088,102...96,091,160
Ensembl chr 4:96,088,201...96,091,156 		JBrowse link
G S1PR2 sphingosine-1-phosphate receptor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26518876 NCBI chr 2:69,050,396...69,057,270
Ensembl chr 2:69,049,270...69,057,270 		JBrowse link
G SEPTIN9 septin 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20388789 NCBI chr12:4,254,771...4,347,526
Ensembl chr12:4,254,775...4,405,628 		JBrowse link
G SET SET nuclear proto-oncogene ISO CTD Direct Evidence: marker/mechanism CTD PMID:24555657 NCBI chr 1:269,050,447...269,064,462 JBrowse link
G SLC39A10 solute carrier family 39 member 10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17359283 NCBI chr15:99,584,830...99,724,621
Ensembl chr15:99,584,872...99,724,611 		JBrowse link
G SLC6A12 solute carrier family 6 member 12 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26213588 NCBI chr 5:67,550,285...67,573,858
Ensembl chr 5:67,550,289...67,572,588 		JBrowse link
G SMPD1 sphingomyelin phosphodiesterase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24951586 NCBI chr 9:3,324,091...3,328,493
Ensembl chr 9:3,324,442...3,328,457 		JBrowse link
G SNAI1 snail family transcriptional repressor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22580338 PMID:24014025 NCBI chr17:51,546,446...51,552,498
Ensembl chr17:51,546,477...51,552,499 		JBrowse link
G SNAI2 snail family transcriptional repressor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22580338 NCBI chr 4:79,264,880...79,268,475
Ensembl chr 4:79,264,880...79,268,475 		JBrowse link
G SOD2 superoxide dismutase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:10853026 PMID:11053990 PMID:15048980 PMID:15654357 PMID:21749277 More... NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,679,352...7,689,560 		JBrowse link
G SORL1 sortilin related receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26213588 NCBI chr 9:48,435,350...48,653,670
Ensembl chr 9:48,435,345...48,653,655 		JBrowse link
G SOX11 SRY-box transcription factor 11 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26213588 NCBI chr 3:129,797,438...129,800,568
Ensembl chr 3:129,798,854...129,800,197 		JBrowse link
G SOX9 SRY-box transcription factor 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:32682831 NCBI chr12:8,642,154...8,647,315
Ensembl chr12:8,642,158...8,647,315 		JBrowse link
G SP1 Sp1 transcription factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:26317792 PMID:35072892 NCBI chr 5:18,588,763...18,633,177
Ensembl chr 5:18,588,758...18,630,089 		JBrowse link
G SRC SRC proto-oncogene, non-receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:18844224 PMID:21291860 NCBI chr17:40,470,970...40,524,862
Ensembl chr17:40,471,009...40,524,860 		JBrowse link
G STAT3 signal transducer and activator of transcription 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26101800 NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992 		JBrowse link
G SUMO1 small ubiquitin like modifier 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15048980 NCBI chr15:105,820,237...105,850,099
Ensembl chr15:105,818,858...105,850,233 		JBrowse link
G TBX15 T-box transcription factor 15 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26213588 NCBI chr 4:101,918,891...102,032,280 JBrowse link
G TF transferrin ISO CTD Direct Evidence: marker/mechanism CTD PMID:20390345 NCBI chr13:74,930,655...74,970,599
Ensembl chr13:74,930,655...74,972,763 		JBrowse link
G TFPI2 tissue factor pathway inhibitor 2 ISO RGD PMID:11687973 RGD:11060269 NCBI chr 9:73,684,236...73,694,663
Ensembl chr 9:73,673,535...73,689,095 		JBrowse link
G TGFB1 transforming growth factor beta 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23992306 PMID:24727557 PMID:24793912 PMID:25884904 PMID:26896736 More... NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,173...49,349,046 		JBrowse link
G TGIF1 TGFB induced factor homeobox 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25791921 NCBI chr 6:103,226,395...103,234,591
Ensembl chr 6:103,226,402...103,234,610 		JBrowse link
G TIMP1 TIMP metallopeptidase inhibitor 1 ISO CTD Direct Evidence: therapeutic CTD PMID:1318976 NCBI chr  X:42,103,251...42,106,289
Ensembl chr  X:42,102,172...42,106,296 		JBrowse link
G TIMP3 TIMP metallopeptidase inhibitor 3 ISO CTD Direct Evidence: therapeutic CTD PMID:23109338 NCBI chr 5:12,185,816...12,242,599
Ensembl chr 5:12,185,818...12,242,581 		JBrowse link
G TKT transketolase ISO CTD Direct Evidence: marker/mechanism CTD PMID:15654357 NCBI chr13:35,348,921...35,377,518
Ensembl chr13:35,348,915...35,377,587 		JBrowse link
G TLN1 talin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21291860 NCBI chr 1:236,416,041...236,450,978
Ensembl chr 1:236,416,044...236,450,922 		JBrowse link
G TLR4 toll like receptor 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21473897 NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,058,970 		JBrowse link
G TMEM139 transmembrane protein 139 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26213588 NCBI chr18:6,970,887...6,974,130
Ensembl chr18:6,970,891...6,973,394 		JBrowse link
G TNF tumor necrosis factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:22199285 PMID:23431386 PMID:23899529 PMID:24613819 NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416 		JBrowse link
G TP53BP2 tumor protein p53 binding protein 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28650484 NCBI chr10:19,823,932...19,889,883
Ensembl chr10:19,823,936...19,889,869 		JBrowse link
G TRIM47 tripartite motif containing 47 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31981573 NCBI chr12:5,535,259...5,539,721
Ensembl chr12:5,535,236...5,539,715 		JBrowse link
G TRPM7 transient receptor potential cation channel subfamily M member 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30710498 NCBI chr 1:121,146,093...121,250,227
Ensembl chr 1:121,146,117...121,250,224 		JBrowse link
G TWIST1 twist family bHLH transcription factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22155737 NCBI chr 9:88,286,911...88,290,131
Ensembl chr 9:88,289,407...88,290,015 		JBrowse link
G TXN thioredoxin ISO CTD Direct Evidence: marker/mechanism CTD PMID:15048980 NCBI chr 1:251,264,180...251,278,000
Ensembl chr 1:251,263,175...251,277,988 		JBrowse link
G UBQLN1 ubiquilin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24747970 NCBI chr10:31,275,916...31,317,521
Ensembl chr10:31,275,868...31,317,516 		JBrowse link
G VIM vimentin ISO CTD Direct Evidence: marker/mechanism CTD PMID:27811057 NCBI chr10:43,516,441...43,526,172
Ensembl chr10:43,517,307...43,526,170 		JBrowse link
G XPC XPC complex subunit, DNA damage recognition and repair factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:27777383 NCBI chr13:70,348,841...70,397,194
Ensembl chr13:70,348,864...70,397,772 		JBrowse link
G XRCC3 X-ray repair cross complementing 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21283680
G YAP1 Yes1 associated transcriptional regulator ISO CTD Direct Evidence: marker/mechanism CTD PMID:34351699 NCBI chr 9:32,811,629...32,924,926
Ensembl chr 9:32,811,416...32,925,603 		JBrowse link
G ZBTB16 zinc finger and BTB domain containing 16 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26213588 NCBI chr 9:41,639,536...41,839,254
Ensembl chr 9:41,639,701...41,836,742 		JBrowse link
G ZEB1 zinc finger E-box binding homeobox 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21954225 NCBI chr10:42,013,114...42,216,139
Ensembl chr10:42,013,084...42,214,205 		JBrowse link
G ZEB2 zinc finger E-box binding homeobox 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21954225 NCBI chr15:7,498,879...7,631,347
Ensembl chr15:7,499,026...7,632,655 		JBrowse link
G ZFP36 ZFP36 ring finger protein ISO CTD Direct Evidence: therapeutic CTD PMID:25556371 NCBI chr 6:48,063,732...48,066,235
Ensembl chr 6:48,063,677...48,066,250 		JBrowse link
G ZFR zinc finger RNA binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:34323000 NCBI chr16:18,561,909...18,656,341
Ensembl chr16:18,560,280...18,656,294 		JBrowse link
G ZNF367 zinc finger protein 367 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34351699 NCBI chr10:25,707,711...25,735,073
Ensembl chr10:25,707,722...25,735,067 		JBrowse link
Neoplasm Metastasis term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12015757 NCBI chr 9:93,049,955...93,146,469 JBrowse link
G ABCC4 ATP binding cassette subfamily C member 4 (PEL blood group) ISO CTD Direct Evidence: marker/mechanism CTD PMID:17003774 NCBI chr11:64,089,149...64,309,831 JBrowse link
G ACE angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18059164 NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703 		JBrowse link
G ACKR3 atypical chemokine receptor 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22180778 NCBI chr15:136,370,457...136,382,559
Ensembl chr15:136,370,530...136,382,553 		JBrowse link
G ACSBG1 acyl-CoA synthetase bubblegum family member 1 ISO associated with pheochromocytoma RGD PMID:29067245 RGD:13831131 NCBI chr 7:47,705,091...47,760,797
Ensembl chr 7:47,705,121...47,762,538 		JBrowse link
G ACVR2A activin A receptor type 2A exacerbates ISO associated with colon cancer;mRNA,protein:decreased expression:colon (human) RGD PMID:30310521 RGD:151361136 NCBI chr15:4,177,333...4,259,056
Ensembl chr15:4,173,805...4,259,706 		JBrowse link
G ADGRB1 adhesion G protein-coupled receptor B1 ISO associated with colorectal cancer RGD PMID:9772287 RGD:13831353 NCBI chr 4:1,582,321...1,658,639
Ensembl chr 4:1,582,330...1,647,573 		JBrowse link
G ADORA2B adenosine A2b receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:27590504 NCBI chr12:59,431,834...59,449,701
Ensembl chr12:59,431,513...59,449,672 		JBrowse link
G AGTR1 angiotensin II receptor type 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18059164 NCBI chr13:88,934,873...88,980,317
Ensembl chr13:88,934,868...88,983,105 		JBrowse link
G AGTR2 angiotensin II receptor type 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18059164 NCBI chr  X:95,267,709...95,272,237
Ensembl chr  X:95,269,300...95,270,388 		JBrowse link
G AHR aryl hydrocarbon receptor ISO CTD Direct Evidence: therapeutic CTD PMID:21948867 NCBI chr 9:86,511,866...86,555,950
Ensembl chr 9:86,511,369...86,555,943 		JBrowse link
G AKIRIN2 akirin 2 ISO RGD PMID:18460465 RGD:2306009 NCBI chr 1:56,047,188...56,075,342
Ensembl chr 1:56,046,327...56,070,163 		JBrowse link
G AKT2 AKT serine/threonine kinase 2 ISO associated with Mammary Neoplasms, Experimental RGD PMID:19491266 RGD:2315599 NCBI chr 6:48,555,785...48,620,472
Ensembl chr 6:48,555,795...48,587,919 		JBrowse link
G ALDOA aldolase, fructose-bisphosphate A ISO CTD Direct Evidence: marker/mechanism CTD PMID:20562527 NCBI chr 3:18,246,036...18,260,167
Ensembl chr 3:18,253,384...18,260,163 		JBrowse link
G ALK ALK receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:22986231 PMID:22999080 NCBI chr 3:109,411,146...110,105,755 JBrowse link
G ALOX5 arachidonate 5-lipoxygenase ISO CTD Direct Evidence: marker/mechanism CTD PMID:20061081 NCBI chr14:90,859,209...90,907,084
Ensembl chr14:90,859,016...90,907,094 		JBrowse link
G AMIGO2 adhesion molecule with Ig like domain 2 ISO Liver Metastasis RGD PMID:28272394 RGD:14394499 NCBI chr 5:77,642,144...77,645,748
Ensembl chr 5:77,642,195...77,645,753 		JBrowse link
G ANGPTL4 angiopoietin like 4 ISO CTD Direct Evidence: therapeutic CTD PMID:17130448 NCBI chr 2:70,905,767...70,912,892
Ensembl chr 2:70,904,531...70,912,974 		JBrowse link
G ANTXR1 ANTXR cell adhesion molecule 1 ISO associated with Mammary Neoplasms, Experimental; RGD PMID:22085271 RGD:9684855 NCBI chr 3:73,157,744...73,398,379
Ensembl chr 3:73,157,747...73,398,379 		JBrowse link
G ANXA1 annexin A1 treatment ISO associated with Mammary Neoplasms, Experimental
associated with Mammary Neoplasms, Experimental;protein:increased expression:lung
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:9514092 PMID:20308542 PMID:20821804 RGD:2306939 RGD:7421541 RGD:7421563 NCBI chr 1:226,414,200...226,431,963
Ensembl chr 1:226,414,306...226,432,279 		JBrowse link
G ANXA4 annexin A4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17085005 NCBI chr 3:72,623,311...72,654,591
Ensembl chr 3:72,622,358...72,694,212 		JBrowse link
G ANXA7 annexin A7 ISO associated with Breast Neoplasms;protein:increased expression:breast
associated with Prostatic Neoplasms;protein:decreased expression:prostate gland		 RGD PMID:11287641 PMID:15073110 RGD:2292655 RGD:2292656 NCBI chr14:76,205,238...76,234,646
Ensembl chr14:76,205,232...76,234,631 		JBrowse link
G APOE apolipoprotein E ISO RGD PMID:22469977 RGD:7771597 NCBI chr 6:51,373,113...51,375,333
Ensembl chr 6:51,372,292...51,375,330 		JBrowse link
G ARHGDIA Rho GDP dissociation inhibitor alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:20562527 NCBI chr12:1,113,358...1,117,319
Ensembl chr12:1,113,379...1,119,315 		JBrowse link
G ARID1A AT-rich interaction domain 1A disease_progression ISO in lung; associated with hepatocellular carcinoma RGD PMID:25975202 RGD:125097495 NCBI chr 6:84,049,729...84,124,302
Ensembl chr 6:84,049,087...84,123,349 		JBrowse link
G ATP6V1C1 ATPase H+ transporting V1 subunit C1 ISO associated with Mammary Neoplasms, Experimental RGD PMID:24155661 RGD:14700647 NCBI chr 4:34,033,943...34,084,990
Ensembl chr 4:34,029,295...34,222,405 		JBrowse link
G AXL AXL receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:26206560 NCBI chr 6:49,245,802...49,277,917
Ensembl chr 6:49,245,673...49,277,914 		JBrowse link
G AZIN1 antizyme inhibitor 1 ISO associated with stomach cancer;RNA:increased editing:stomach
associated with colorectal cancer;RNA:increased editing:colorectum		 RGD PMID:29925690 PMID:30563560 RGD:14700703 RGD:14700704 NCBI chr 4:34,221,368...34,257,261
Ensembl chr 4:34,234,679...34,257,134 		JBrowse link
G BAX BCL2 associated X, apoptosis regulator ISO associated with Carcinoma, Infiltrating Duct RGD PMID:17288732 RGD:1643356 NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,140 		JBrowse link
G BCL2 BCL2 apoptosis regulator ISO associated with Carcinoma, Renal Cell
associated with Breast Neoplasms		 RGD PMID:12810203 PMID:16826579 RGD:2293020 RGD:2293021 NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879 		JBrowse link
G BMP6 bone morphogenetic protein 6 severity ISO associated with Prostatic Neoplasms;protein:increased expression:bone RGD PMID:16166304 RGD:2289018 NCBI chr 7:5,058,817...5,208,868
Ensembl chr 7:5,058,817...5,210,270 		JBrowse link
G BMP7 bone morphogenetic protein 7 disease_progression ISO associated with Prostatic Neoplasms;mRNA:increased expression:bone
associated with Breast Neoplasms;protein:increased expression:breast		 RGD PMID:12539225 PMID:17895257 RGD:2289029 RGD:2289033 NCBI chr17:57,567,770...57,676,516
Ensembl chr17:57,584,956...57,675,986 		JBrowse link
G BRAF B-Raf proto-oncogene, serine/threonine kinase onset ISO associated with Melanoma; DNA:mutations: : RGD PMID:25623140 RGD:11567259 NCBI chr18:8,957,963...9,132,558
Ensembl chr18:8,957,991...9,132,553 		JBrowse link
G BRD4 bromodomain containing 4 ISO RGD PMID:23950209 RGD:9586346 NCBI chr 2:62,250,958...62,345,851
Ensembl chr 2:62,250,989...62,345,362 		JBrowse link
G BRMS1 BRMS1 transcriptional repressor and anoikis regulator ISO CTD Direct Evidence: therapeutic CTD PMID:27501413 NCBI chr 2:6,046,077...6,053,672
Ensembl chr 2:6,046,098...6,053,667 		JBrowse link
G BSG basigin ISO CTD Direct Evidence: marker/mechanism CTD PMID:21956400 NCBI chr 2:77,735,586...77,743,451 JBrowse link
G CAB39 calcium binding protein 39 ISO associated with hepatocellular carcinoma; RGD PMID:28605041 RGD:14398832 NCBI chr15:131,492,575...131,584,963
Ensembl chr15:131,492,578...131,584,962 		JBrowse link
G CACYBP calcyclin binding protein ISO associated with pancreatic neoplasms RGD PMID:18765951 RGD:2326146 NCBI chr 9:117,062,303...117,077,442
Ensembl chr 9:117,064,187...117,123,126 		JBrowse link
G CAP1 cyclase associated actin cytoskeleton regulatory protein 1 ISO associated with Pancreatic Neoplasms; mRNA, protein:increased expression:pancreas RGD PMID:19188911 RGD:2326238 NCBI chr 6:95,811,485...95,840,576
Ensembl chr 6:95,812,179...95,840,570 		JBrowse link
G CASP3 caspase 3 ISO associated with Breast Neoplasms RGD PMID:18064531 RGD:2293306 NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213 		JBrowse link
G CAT catalase ISO CTD Direct Evidence: therapeutic CTD PMID:12538496 PMID:22580338 PMID:23518002 NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452 		JBrowse link
G CAV1 caveolin 1 treatment ISO associated with Mammary Neoplasms, Experimental
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:15334058 PMID:15355971 PMID:20562527 RGD:2289106 RGD:8661780 NCBI chr18:29,648,120...29,682,451
Ensembl chr18:29,649,992...29,682,465 		JBrowse link
G CBX4 chromobox 4 ISO associated with Carcinoma, Hepatocellular; RGD PMID:24838576 RGD:9586738 NCBI chr12:2,520,913...2,527,245
Ensembl chr12:2,521,027...2,527,241 		JBrowse link
G CBX5 chromobox 5 ISO associated with Lung Neoplasms; RGD PMID:22900142 RGD:9586743 NCBI chr 5:19,446,083...19,484,527
Ensembl chr 5:19,446,086...19,484,463 		JBrowse link
G CCL2 chemokine (C-C motif) ligand 2 ISO associated with Mammary Neoplasms, Experimental RGD PMID:19629725 RGD:4891450 NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026 		JBrowse link
G CCL20 C-C motif chemokine ligand 20 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30603057 NCBI chr15:129,172,743...129,176,069 JBrowse link
G CCL3L1 chemokine (C-C motif) ligand 3-like 1 ISO RGD PMID:18941229 RGD:7241810 NCBI chr12:39,491,999...39,493,345
Ensembl chr12:39,491,914...39,493,774 		JBrowse link
G CCL5 C-C motif chemokine ligand 5 treatment ISO associated with Animal Mammary Neoplasms; RGD PMID:15692764 RGD:14995455 NCBI chr12:39,652,731...39,659,121
Ensembl chr12:39,648,598...39,659,118 		JBrowse link
G CCN4 cellular communication network factor 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30723155 NCBI chr 4:8,078,163...8,110,906
Ensembl chr 4:8,079,755...8,110,700 		JBrowse link
G CCNA2 cyclin A2 ISO associated with Seminoma;protein:increased expression:testis RGD PMID:14696091 RGD:2293346 NCBI chr 8:102,260,346...102,266,274
Ensembl chr 8:102,260,215...102,266,309 		JBrowse link
G CCND1 cyclin D1 treatment ISO associated with Carcinoma, Non-Small-Cell Lung;mRNA:splice variant
associated with stomach cancer; human cells in mouse model 		RGD PMID:18715616 PMID:27431311 RGD:13434926 RGD:152995400 NCBI chr 2:3,621,242...3,633,380
Ensembl chr 2:3,621,246...3,633,296 		JBrowse link
G CCND2 cyclin D2 ISO associated with Breast Neoplasms;DNA:hypermethylated:brain RGD PMID:15131050 RGD:2289155 NCBI chr 5:66,092,483...66,114,575
Ensembl chr 5:66,087,379...66,114,571 		JBrowse link
G CCNE1 cyclin E1 disease_progression ISO protein:altered processing
associated with non-small cell lung carcinoma		 RGD PMID:11212263 PMID:17671189 RGD:13673913 RGD:2289229 NCBI chr 6:39,919,541...39,933,224
Ensembl chr 6:39,919,624...39,933,363 		JBrowse link
G CCR5 C-C motif chemokine receptor 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:35072892 NCBI chr13:29,382,383...29,387,902
Ensembl chr13:29,383,303...29,387,895 		JBrowse link
G CD274 CD274 molecule disease_progression ISO associated with ovarian cancer RGD PMID:23340297 RGD:41410797 NCBI chr 1:216,646,378...216,792,731
Ensembl chr 1:216,660,041...216,792,724 		JBrowse link
G CD44 CD44 molecule ISO associated with Carcinoma, Renal Cell;protein:increased expression:kidney
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:18026989 PMID:23098472 RGD:2289347 NCBI chr 2:25,788,699...25,884,209
Ensembl chr 2:25,788,703...25,884,153 		JBrowse link
G CD82 CD82 molecule ISO CTD Direct Evidence: therapeutic
associated with Carcinoma, Infiltrating Duct;mRNA:decreased expression:brain
associated with Prostatic Neoplasms;DNA:loss of heterozygosity
associated with Prostatic Neoplasms;mRNA:decreased expression
associated with Prostatic Neoplasms;mRNA:decreased expression:bone
associated with Carcinoma, Hepatocellular;mRNA:decreased expression		 CTD
RGD		 PMID:9254900 PMID:9831222 PMID:11275982 PMID:12806379 PMID:15592684 More... RGD:2289400 RGD:2289402 RGD:2289407 RGD:2289425 RGD:68869 NCBI chr 2:17,751,153...17,803,172
Ensembl chr 2:17,750,660...17,803,126 		JBrowse link
G CD86 CD86 molecule ISO mRNA:decreased expression:mediastinal lymph node (rat) RGD PMID:18360875 RGD:4892237 NCBI chr13:138,427,573...138,504,307
Ensembl chr13:138,427,533...138,504,310 		JBrowse link
G CDH1 cadherin 1 treatment ISO associated with Prostatic Neoplasms
associated with stomach cancer; human cells in mouse model
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:17520682 PMID:18008331 PMID:22580338 PMID:27431311 RGD:152995400 RGD:2289488 NCBI chr 6:18,075,487...18,155,986
Ensembl chr 6:18,075,480...18,155,986 		JBrowse link
G CDH2 cadherin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23876460 NCBI chr 6:112,396,713...112,629,073
Ensembl chr 6:112,396,721...112,628,432 		JBrowse link
G CDKL2 cyclin dependent kinase like 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25333262 NCBI chr 8:71,231,148...71,260,902
Ensembl chr 8:71,231,152...71,260,815 		JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A ISO associated with Melanoma; RGD PMID:9194578 RGD:8662817 NCBI chr 7:32,354,776...32,363,771
Ensembl chr 7:32,359,455...32,363,761 		JBrowse link
G CDKN2A cyclin dependent kinase inhibitor 2A ISO associated with Paraganglioma, Extra-Adrenal;DNA:hypermethylation RGD PMID:18509008 RGD:8552280 NCBI chr 1:200,774,496...200,799,149
Ensembl chr 1:200,792,469...200,798,854 		JBrowse link
G CFL1 cofilin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20562527 NCBI chr 2:6,471,558...6,475,019
Ensembl chr 2:6,469,254...6,475,035 		JBrowse link
G CGA glycoprotein hormones, alpha polypeptide ISO associated with Breast Neoplasms;protein:increased expression:serum RGD PMID:6768680 RGD:2293637 NCBI chr 1:55,552,675...55,569,057
Ensembl chr 1:55,551,320...55,568,991 		JBrowse link
G CHEK1 checkpoint kinase 1 ISO associated with Pancreatic Neoplasms RGD PMID:15448002 RGD:2317235 NCBI chr 9:52,759,224...52,790,878
Ensembl chr 9:52,753,528...52,790,700 		JBrowse link
G CHUK component of inhibitor of nuclear factor kappa B kinase complex ISO associated with prostate adenocarcinoma RGD PMID:17377533 RGD:2298657 NCBI chr14:111,316,178...111,351,669
Ensembl chr14:111,315,141...111,351,868 		JBrowse link
G CIC capicua transcriptional repressor ISO CTD Direct Evidence: marker/mechanism CTD PMID:27869830 NCBI chr 6:49,638,986...49,664,146
Ensembl chr 6:49,638,990...49,662,947 		JBrowse link
G CLDN7 claudin 7 ISO RGD PMID:23390083 RGD:9685143 NCBI chr12:52,612,517...52,628,376
Ensembl chr12:52,612,510...52,628,362 		JBrowse link
G CLIC1 chloride intracellular channel 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20562527 NCBI chr 7:23,842,829...23,851,162 JBrowse link
G CLU clusterin ISO associated with Breast Neoplasms RGD PMID:20307318 RGD:8883512 NCBI chr14:11,336,585...11,352,569
Ensembl chr14:11,336,595...11,349,764 		JBrowse link
G CREB1 cAMP responsive element binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29179997 NCBI chr15:110,705,548...110,773,037
Ensembl chr15:110,705,496...110,771,728 		JBrowse link
G CSF1 colony stimulating factor 1 ISO associated with Prostatic Neoplasms RGD PMID:18510570 RGD:2293638 NCBI chr 4:110,178,466...110,198,232
Ensembl chr 4:110,178,475...110,197,900 		JBrowse link
G CSF1R colony stimulating factor 1 receptor exacerbates ISO associated with Prostatic Neoplasms
associated with breast cancer
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:1390197 PMID:18510570 PMID:25005824 RGD:150524287 RGD:2293638 NCBI chr 2:151,102,138...151,130,311
Ensembl chr 2:151,102,147...151,147,633 		JBrowse link
G CSF3 colony stimulating factor 3 ISO CTD Direct Evidence: therapeutic CTD PMID:7543699 PMID:9018096 NCBI chr12:22,333,445...22,335,949
Ensembl chr12:22,333,449...22,338,753 		JBrowse link
G CST3 cystatin C ISO protein:decreased expression:cerebrospinal fluid RGD PMID:12589965 RGD:5686394 NCBI chr17:30,471,056...30,474,486
Ensembl chr17:30,470,855...30,474,590 		JBrowse link
G CTLA4 cytotoxic T-lymphocyte associated protein 4 disease_progression ISO associated with Mammary Neoplasms, Experimental RGD PMID:15701862 PMID:18049334 RGD:4891518 RGD:7204722 NCBI chr15:107,283,081...107,288,041
Ensembl chr15:107,282,927...107,289,103 		JBrowse link
G CTNNB1 catenin beta 1 ISO associated with Prostatic Neoplasms
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:18008331 PMID:29106415 RGD:2289488 NCBI chr13:25,163,550...25,208,314
Ensembl chr13:25,164,277...25,208,311 		JBrowse link
G CTSB cathepsin B ISO protein:increased expression:cerebrospinal fluid RGD PMID:12589965 RGD:5686394 NCBI chr14:15,014,139...15,035,081
Ensembl chr14:15,011,711...15,033,877 		JBrowse link
G CTSD cathepsin D ISO protein:increased expression:oral cavity, oropharynx, hypopharynx (human) RGD PMID:10562684 RGD:1547892 NCBI chr 2:1,188,548...1,197,642
Ensembl chr 2:1,188,549...1,197,643 		JBrowse link
G CTSH cathepsin H ISO protein:increased expression:cerebrospinal fluid RGD PMID:12589965 RGD:5686394 NCBI chr 7:48,084,882...48,106,072
Ensembl chr 7:48,083,572...48,106,072 		JBrowse link
G CTU2 cytosolic thiouridylase subunit 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27811057 NCBI chr 6:964,551...976,881
Ensembl chr 6:964,566...976,832 		JBrowse link
G CX3CR1 C-X3-C motif chemokine receptor 1 susceptibility ISO associated with Breast Neoplasms RGD PMID:16627550 RGD:4892015 NCBI chr13:23,944,386...23,957,567
Ensembl chr13:23,944,369...23,957,486 		JBrowse link
G CXCL12 C-X-C motif chemokine ligand 12 treatment ISO associated with Pancreatic Carcinoma
associated with Pancreatic Neoplasms
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:12761880 PMID:21312072 PMID:23743303 PMID:26330165 RGD:10398726 RGD:2317610 NCBI chr14:91,516,383...91,543,857
Ensembl chr14:91,516,431...91,552,752 		JBrowse link
G CXCR3 C-X-C motif chemokine receptor 3 ISO associated with Mammary Neoplasms, Experimental RGD PMID:16885372 RGD:5135487 NCBI chr  X:57,592,032...57,595,706
Ensembl chr  X:57,592,038...57,595,692 		JBrowse link
G CXCR4 C-X-C motif chemokine receptor 4 ameliorates
disease_progression
severity		 ISO CTD Direct Evidence: marker/mechanism
associated with Otorhinolaryngologic Neoplasms;mRNA,protein:increased expression:Laryngeal and hypopharyngeal tissue (human)
associated with lung non-small cell carcinoma;mRNA,protein:increased expression:lung (human)
associated with oral squamous cell carcinoma
associated with lung non-small cell carcinoma; protein:increased expression:lung (human)
associated with pancreatic cancer
associated with lung cancer; human cells in mouse model
human cells in mouse model;associated with lung cancer
associated with osteosarcoma;protein:increased expression:bone (human)		 CTD
RGD		 PMID:16230077 PMID:16322285 PMID:17634424 PMID:18487224 PMID:21312072 More... RGD:151708730 RGD:152023741 RGD:152023745 RGD:152023746 RGD:152025556 RGD:152177475 RGD:152177476 RGD:152177478 RGD:152177479 NCBI chr15:15,663,652...15,666,706
Ensembl chr15:15,663,494...15,667,232 		JBrowse link
G CYP19A3 cytochrome P450 19A3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28112739 NCBI chr 1:120,476,890...120,556,103
Ensembl chr 1:120,367,667...120,695,899 		JBrowse link
G DAB2IP DAB2 interacting protein severity ISO associated with colorectal cancer;protein:decreased expression:colorectum (human) RGD PMID:26336990 RGD:11531913 NCBI chr 1:261,732,280...261,859,833
Ensembl chr 1:261,659,660...261,859,022 		JBrowse link
G DAPK1 death associated protein kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17319784 NCBI chr10:27,724,644...27,954,708
Ensembl chr10:27,724,648...27,954,350 		JBrowse link
G DAXX death domain associated protein ISO RGD PMID:23539629 RGD:9587820 NCBI chr 7:29,676,854...29,681,145
Ensembl chr 7:29,676,856...29,681,110 		JBrowse link
G DCN decorin ISO associated with Breast Neoplasms RGD PMID:18688028 RGD:2311418 NCBI chr 5:91,678,601...91,713,925
Ensembl chr 5:91,682,658...91,714,235 		JBrowse link
G DDR1 discoidin domain receptor tyrosine kinase 1 severity ISO mRNA:increased expression:ovary (human)
protein:increased expression:bone (human)		 RGD PMID:28743276 PMID:29039472 RGD:151347541 RGD:151347601 NCBI chr 7:23,371,358...23,391,585
Ensembl chr 7:23,373,845...23,391,584 		JBrowse link
G DDR2 discoidin domain receptor tyrosine kinase 2 ameliorates ISO associated with melanoma; RGD PMID:24293323 RGD:150429711 NCBI chr 4:87,749,738...87,911,818
Ensembl chr 4:87,756,168...87,911,296 		JBrowse link
G DDX3X DEAD-box helicase 3 X-linked ISO human cells in mouse model RGD PMID:26087195 RGD:11096798 NCBI chr  X:36,988,031...37,005,496
Ensembl chr  X:36,988,031...37,018,202 		JBrowse link
G DEK DEK proto-oncogene ISO CTD Direct Evidence: marker/mechanism CTD PMID:27811057 NCBI chr 7:13,901,562...13,935,477
Ensembl chr 7:13,872,775...13,935,173 		JBrowse link
G DHFR dihydrofolate reductase disease_progression ISO CTD Direct Evidence: marker/mechanism RGD
CTD		 PMID:8149482 PMID:19159907 RGD:11040442 NCBI chr 2:89,230,660...89,255,830 JBrowse link
G DIO3 iodothyronine deiodinase 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26825960
G DMD dystrophin ISO CTD Direct Evidence: marker/mechanism CTD PMID:24793134 NCBI chr  X:27,028,223...29,650,728
Ensembl chr  X:27,028,231...28,383,840 		JBrowse link
G DNMT3B DNA methyltransferase 3 beta ISO associated with Uterine Cervical Neoplasms; RGD PMID:22330137 RGD:9589117 NCBI chr17:36,345,715...36,386,076
Ensembl chr17:36,345,816...36,386,072 		JBrowse link
G DPYD dihydropyrimidine dehydrogenase treatment ISO CTD Direct Evidence: marker/mechanism
associated with Colonic Neoplasms		 CTD
RGD		 PMID:11383214 PMID:17611699 RGD:11251755 NCBI chr 4:119,931,471...120,712,461
Ensembl chr 4:119,931,414...120,712,459 		JBrowse link
G E2F1 E2F transcription factor 1 severity ISO protein:increased expression:bone (human) RGD PMID:29039472 RGD:151347601 NCBI chr17:37,178,587...37,190,118
Ensembl chr17:37,178,599...37,189,883 		JBrowse link
G E2F8 E2F transcription factor 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27683099 NCBI chr 2:40,178,182...40,194,932
Ensembl chr 2:40,178,177...40,194,935 		JBrowse link
G EDN1 endothelin 1 ISO RGD PMID:12941866 RGD:734914 NCBI chr 7:8,752,018...8,758,354
Ensembl chr 7:8,751,695...8,758,348 		JBrowse link
G EDNRA endothelin receptor type A ISO associated with Bladder Neoplasms RGD PMID:21183790 RGD:4892282 NCBI chr 8:81,210,750...81,279,053
Ensembl chr 8:81,209,327...81,276,853 		JBrowse link
G EEF1B2 eukaryotic translation elongation factor 1 beta 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17085005 PMID:20562527 NCBI chr15:109,451,901...109,455,529
Ensembl chr15:109,451,514...109,455,525 		JBrowse link
G EEF2 eukaryotic translation elongation factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20562527 NCBI chr 2:74,746,541...74,756,687
Ensembl chr 2:74,747,080...74,756,680 		JBrowse link
G EFNB2 ephrin B2 ISO associated with cholangiocarcinoma;protein:increased expression:biliary ductule (human) RGD PMID:25012246 RGD:153305948 NCBI chr11:74,188,337...74,232,768
Ensembl chr11:74,186,640...74,233,354 		JBrowse link
G EGF epidermal growth factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:21942447 PMID:23064031 NCBI chr 8:112,235,607...112,330,062
Ensembl chr 8:112,234,386...112,330,046 		JBrowse link
G EGFR epidermal growth factor receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:17369752 PMID:17575224 PMID:23867902 NCBI chr 9:139,302,410...139,474,632
Ensembl chr 9:139,300,022...139,475,589 		JBrowse link
G EHMT2 euchromatic histone lysine methyltransferase 2 ISO CTD Direct Evidence: marker/mechanism
associated with lung neoplasms;		 CTD
RGD		 PMID:20940408 PMID:25115793 RGD:9589170 NCBI chr 7:23,977,683...23,992,673
Ensembl chr 7:23,977,683...23,993,478 		JBrowse link
G EIF1AX eukaryotic translation initiation factor 1A X-linked ISO CTD Direct Evidence: marker/mechanism CTD PMID:17085005 NCBI chr  X:16,429,625...16,449,581
Ensembl chr  X:16,429,628...16,449,556 		JBrowse link
G EIF4A2 eukaryotic translation initiation factor 4A2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17085005 NCBI chr13:124,582,822...124,589,296
Ensembl chr13:124,582,898...124,589,293 		JBrowse link
G ELP3 elongator acetyltransferase complex subunit 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27811057 NCBI chr14:11,832,947...11,940,080
Ensembl chr14:11,832,962...11,940,070 		JBrowse link
G EML4 EMAP like 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22986231 PMID:22999080 NCBI chr 3:98,005,809...98,155,876
Ensembl chr 3:98,005,812...98,155,846 		JBrowse link
G ENPP2 ectonucleotide pyrophosphatase/phosphodiesterase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26037280 NCBI chr 4:19,319,815...19,433,492
Ensembl chr 4:19,319,810...19,433,488 		JBrowse link
G EPCAM epithelial cell adhesion molecule ISO RGD PMID:23390083 RGD:9685143 NCBI chr 3:93,169,800...93,185,221
Ensembl chr 3:93,168,852...93,185,653 		JBrowse link
G EPO erythropoietin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16699298 NCBI chr 3:8,620,508...8,622,936
Ensembl chr 3:8,620,508...8,622,936 		JBrowse link
G EPOR erythropoietin receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:16699298 NCBI chr 2:70,063,601...70,068,821
Ensembl chr 2:70,063,519...70,068,821 		JBrowse link
G ERBB2 erb-b2 receptor tyrosine kinase 2 ISO CTD Direct Evidence: marker/mechanism
rat gene in a mouse model		 CTD
RGD		 PMID:11238891 PMID:16984552 RGD:734938 NCBI chr12:22,591,621...22,621,384
Ensembl chr12:22,590,725...22,621,351 		JBrowse link
G ERBB3 erb-b2 receptor tyrosine kinase 3 disease_progression ISO associated with Prostatic Neoplasms;protein:alternative form
associated with lung adenocarcinoma
CTD Direct Evidence: marker/mechanism
associated with Prostatic Neoplasms;protein:increased expression, altered localization:bone, nucleus		 RGD
CTD		 PMID:17634423 PMID:18559590 PMID:26254096 PMID:28114269 RGD:126790470 RGD:2289944 RGD:2298500 NCBI chr 5:21,474,218...21,495,040
Ensembl chr 5:21,474,475...21,495,038 		JBrowse link
G ERBB4 erb-b2 receptor tyrosine kinase 4 disease_progression ISO associated with lung adenocarcinoma RGD PMID:26254096 RGD:126790470 NCBI chr15:113,966,573...115,096,984
Ensembl chr15:113,974,437...115,096,565 		JBrowse link
G ERCC1 ERCC excision repair 1, endonuclease non-catalytic subunit disease_progression ISO CTD Direct Evidence: marker/mechanism
associated with Melanoma		 CTD
RGD		 PMID:20801905 PMID:26202595 RGD:11252177 NCBI chr 6:51,783,537...51,808,898
Ensembl chr 6:51,783,478...51,798,984 		JBrowse link
G ERCC4 ERCC excision repair 4, endonuclease catalytic subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:20372803 NCBI chr 3:29,266,234...29,306,109
Ensembl chr 3:29,269,989...29,306,151 		JBrowse link
G ERP29 endoplasmic reticulum protein 29 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17085005 NCBI chr14:39,687,028...39,695,748
Ensembl chr14:39,687,000...39,695,752 		JBrowse link
G ESR1 estrogen receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20104649 PMID:35044086 NCBI chr 1:14,217,032...14,604,906
Ensembl chr 1:14,217,036...14,493,363 		JBrowse link
G ETV4 ETS variant transcription factor 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27869830 NCBI chr12:19,531,507...19,548,303
Ensembl chr12:19,531,603...19,548,301 		JBrowse link
G EZH2 enhancer of zeste 2 polycomb repressive complex 2 subunit ISO associated with lung non-small cell carcinoma
associated with stomach cancer;protein:increased expression:stomach
associated with osteosarcoma		 RGD PMID:20132185 PMID:24097870 PMID:26265454 RGD:11532507 RGD:126779607 RGD:126781716 NCBI chr 9:109,384,976...109,450,943
Ensembl chr 9:109,385,015...109,450,941 		JBrowse link
G EZR ezrin ISO CTD Direct Evidence: marker/mechanism CTD PMID:27137931 NCBI chr 1:8,403,362...8,452,750
Ensembl chr 1:8,403,453...8,452,742 		JBrowse link
G F2 coagulation factor II, thrombin ISO associated with Carcinoma, Small cell;protein:increased expression:brain RGD PMID:22065054 RGD:6893520 NCBI chr 2:15,793,257...15,819,151
Ensembl chr 2:15,791,455...15,819,137 		JBrowse link
G FADD Fas associated via death domain ISO CTD Direct Evidence: marker/mechanism CTD PMID:16450001 NCBI chr 2:3,191,718...3,194,820
Ensembl chr 2:3,185,675...3,194,818 		JBrowse link
G FAS Fas cell surface death receptor ISO associated with Breast Neoplasms;protein:decreased expression:breast
associated with Mammary Neoplasms;protein:decreased expression:lung		 RGD PMID:17352235 PMID:17918178 RGD:2290048 RGD:2290053 NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716 		JBrowse link
G FASLG Fas ligand ISO associated with Breast Neoplasms;protein:decreased expression:breast RGD PMID:17352235 RGD:2290053 NCBI chr 9:115,068,314...115,075,147
Ensembl chr 9:115,068,090...115,076,464 		JBrowse link
G FGF13 fibroblast growth factor 13 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19917848 NCBI chr  X:113,460,191...113,955,691
Ensembl chr  X:113,460,191...113,932,715 		JBrowse link
G FGFR1 fibroblast growth factor receptor 1 ISO associated with prostate adenocarcinoma RGD PMID:23576558 RGD:13504748 NCBI chr15:48,053,895...48,106,634
Ensembl chr15:48,053,340...48,106,724 		JBrowse link
G FLT1 fms related receptor tyrosine kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21975929 NCBI chr11:5,620,698...5,797,095
Ensembl chr11:5,621,212...5,795,264 		JBrowse link
G FN1 fibronectin 1 treatment ISO associated with stomach cancer; human cells in mouse model RGD PMID:27431311 RGD:152995400 NCBI chr15:117,658,158...117,737,145
Ensembl chr15:117,658,099...117,731,014 		JBrowse link
G FSCN1 fascin actin-bundling protein 1 ISO associated with Pancreatic Neoplasms RGD PMID:15626919 RGD:2317788 NCBI chr 3:4,134,173...4,143,275
Ensembl chr 3:4,134,177...4,143,286 		JBrowse link
G FTL ferritin light chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:17085005 NCBI chr 6:54,231,121...54,232,756
Ensembl chr 6:54,231,172...54,232,750 		JBrowse link
G GAB2 GRB2 associated binding protein 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21996746 NCBI chr 9:12,663,658...12,851,423
Ensembl chr 9:12,663,657...12,851,342 		JBrowse link
G GDF15 growth differentiation factor 15 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23996089 NCBI chr 2:59,409,035...59,411,356
Ensembl chr 2:59,408,904...59,411,358 		JBrowse link
G GJB1 gap junction protein beta 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17978847 NCBI chr  X:57,241,990...57,249,496
Ensembl chr  X:57,242,045...57,249,885 		JBrowse link
G GP1BA glycoprotein Ib platelet subunit alpha ISO associated with Melanoma, Experimental RGD PMID:19727118 RGD:10450866 NCBI chr12:51,975,810...51,979,428
Ensembl chr12:51,975,874...51,977,757 		JBrowse link
G GPCPD1 glycerophosphocholine phosphodiesterase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25482527 NCBI chr17:14,420,656...14,476,223
Ensembl chr17:14,420,658...14,476,212 		JBrowse link
G GPI glucose-6-phosphate isomerase ISO RGD PMID:20978190 RGD:11051956 NCBI chr 6:44,038,374...44,069,331
Ensembl chr 6:44,038,357...44,069,328 		JBrowse link
G GPX2 glutathione peroxidase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23867582 NCBI chr 7:89,007,636...89,011,620
Ensembl chr 7:89,007,375...89,011,620 		JBrowse link
G HABP2 hyaluronan binding protein 2 treatment ISO associated with Thyroid Neoplasms RGD PMID:22715430 RGD:11353856 NCBI chr14:123,893,990...123,929,445
Ensembl chr14:123,893,996...123,932,961 		JBrowse link
G HAVCR2 hepatitis A virus cellular receptor 2 disease_progression ISO DNA:polymorphisms: : +4259T>G (human) RGD PMID:22472081 RGD:7245505 NCBI chr16:66,138,157...66,160,568
Ensembl chr16:66,139,535...66,160,538 		JBrowse link
G HDAC3 histone deacetylase 3 ISO associated with Anaphylaxis;
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:24619412 PMID:34973135 RGD:9590165 NCBI chr 2:143,273,188...143,287,421
Ensembl chr 2:143,273,192...143,287,399 		JBrowse link
G HGF hepatocyte growth factor ISO associated with Pancreatic Neoplasms
CTD Direct Evidence: marker/mechanism
associated with Mammary Neoplasms, Experimental;
associated with Melanoma;		 RGD
CTD		 PMID:10688652 PMID:11893931 PMID:16459153 PMID:25971889 RGD:2317904 RGD:8548538 RGD:8548625 NCBI chr 9:98,437,771...98,513,573
Ensembl chr 9:98,438,143...98,513,564 		JBrowse link
G HPSE heparanase ISO CTD Direct Evidence: marker/mechanism CTD PMID:22240343 NCBI chr 8:135,082,199...135,120,887
Ensembl chr 8:135,097,725...135,120,887 		JBrowse link
G HRH2 histamine receptor H2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:6224980 NCBI chr 2:81,883,670...81,932,464
Ensembl chr 2:81,883,673...81,932,275 		JBrowse link
G HSP90AA1 heat shock protein 90 alpha family class A member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20562527
G IBSP integrin binding sialoprotein ISO CTD Direct Evidence: marker/mechanism CTD PMID:22407340 PMID:24980816 NCBI chr 8:131,208,281...131,222,048
Ensembl chr 8:131,208,282...131,241,266 		JBrowse link
G ICAM1 intercellular adhesion molecule 1 ISO associated with Melanoma, Cutaneous Malignant
associated with Pancreatic Neoplasms;protein:increased expression:serum		 RGD PMID:10465581 PMID:12923961 RGD:2325163 RGD:8547593 NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205 		JBrowse link
G ID1 inhibitor of DNA binding 1 ISO CTD Direct Evidence: therapeutic CTD PMID:24910342 NCBI chr17:35,316,518...35,317,742
Ensembl chr17:35,316,514...35,317,736 		JBrowse link
G IGF1 insulin like growth factor 1 ISO CTD Direct Evidence: marker/mechanism
associated with Uveal Melanoma;protein:increased expression:serum:
associated with Pancreatic Neoplasms		 CTD
RGD		 PMID:18398872 PMID:19375852 PMID:23197685 RGD:2317643 RGD:8548834 NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,033 		JBrowse link
G IGF1R insulin like growth factor 1 receptor ISO associated with Pancreatic Neoplasms RGD PMID:16575403 RGD:2317645 NCBI chr 1:137,383,623...137,691,038
Ensembl chr 1:137,387,825...137,691,058 		JBrowse link
G IGF2 insulin like growth factor 2 ISO associated with Arthritis, Experimental; protein:increased expression:lung, bone, serum: RGD PMID:21859454 RGD:5510000 NCBI chr 2:1,469,183...1,496,417 JBrowse link
G IKZF1 IKAROS family zinc finger 1 ISO associated with colorectal cancer;DNA:polymorphisms: RGD PMID:31320627 RGD:150540328 NCBI chr 9:136,372,202...136,464,942
Ensembl chr 9:136,372,725...136,464,940 		JBrowse link
G IL10 interleukin 10 ISO RGD PMID:16035616 RGD:1598627 NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378 		JBrowse link
G IL18 interleukin 18 ISO associated with breast cancer;protein:increased expression:serum
CTD Direct Evidence: marker/mechanism
associated with breast cancer;DNA:SNP:promoter:-137G>C (rs187238) (human)		 RGD
CTD		 PMID:11215816 PMID:12209760 PMID:12748951 PMID:19152241 RGD:4889862 RGD:8655866 RGD:8655899 NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219 		JBrowse link
G IL2 interleukin 2 treatment ISO associated with melanoma
associated with melanoma;
associated with neuroblastoma.
CTD Direct Evidence: therapeutic		 RGD
CTD		 PMID:8610104 PMID:8642346 PMID:9362156 PMID:17105418 RGD:14747043 RGD:14865005 RGD:8663438 NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609 		JBrowse link
G IL6 interleukin 6 treatment ISO associated with stomach cancer, human cells in mouse model
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:21937440 PMID:26101800 PMID:28186964 RGD:127229952 NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263 		JBrowse link
G ITGA6 integrin subunit alpha 6 ISO RGD PMID:13130099 RGD:1302259 NCBI chr15:78,504,108...78,591,779
Ensembl chr15:78,504,078...78,591,777 		JBrowse link
G ITGB1 integrin subunit beta 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23562787 NCBI chr10:56,078,393...56,130,608
Ensembl chr10:56,078,396...56,173,326 		JBrowse link
G ITGB3 integrin subunit beta 3 ISO mRNA, protein:increased expression:lung
associated with renal cell carcinoma;DNA:missense mutation:cds:p.L33P (human)		 RGD PMID:16831169 PMID:21107114 RGD:5037225 RGD:6907406 NCBI chr12:16,694,466...16,752,228
Ensembl chr12:16,693,514...16,752,292 		JBrowse link
G JAK2 Janus kinase 2 treatment ISO associated with stomach cancer, human cells in mouse model RGD PMID:28186964 RGD:127229952 NCBI chr 1:216,849,744...217,002,310
Ensembl chr 1:216,848,689...217,002,148 		JBrowse link
G JUP junction plakoglobin ISO associated with Ovarian Neoplasms RGD PMID:15619205 RGD:2301746 NCBI chr12:20,902,395...20,931,208
Ensembl chr12:20,901,396...20,931,210 		JBrowse link
G KDM6A lysine demethylase 6A disease_progression ISO associated with lung adenocarcinoma;protein:increased expression:brain (human) RGD PMID:33291558 RGD:150429741 NCBI chr  X:39,953,764...40,154,197
Ensembl chr  X:39,953,814...40,154,029 		JBrowse link
G KDR kinase insert domain receptor ISO associated with Carcinoma, Renal Cell RGD PMID:17465216 RGD:2301757 NCBI chr 8:41,809,116...41,856,379
Ensembl chr 8:41,809,122...41,856,336 		JBrowse link
G KIF2C kinesin family member 2C disease_progression ISO associated with colorectal cancer RGD PMID:18506187 RGD:27372891 NCBI chr 6:166,556,765...166,577,904
Ensembl chr 6:166,556,776...166,577,904 		JBrowse link
G KMT2B lysine methyltransferase 2B ISO associated with lung adenocarcinoma RGD PMID:33291558 RGD:150429741 NCBI chr 6:45,146,863...45,166,854
Ensembl chr 6:45,147,566...45,166,852 		JBrowse link
G KMT2D lysine methyltransferase 2D disease_progression ISO associated with colorectal cancer;DNA:mutations:: RGD PMID:27875625 RGD:155582219 NCBI chr 5:15,049,827...15,091,622 JBrowse link
G KRAS KRAS proto-oncogene, GTPase disease_progression
treatment		 ISO associated with colorectal cancer;DNA:mutation: :
associated with stomach cancer; human cells in mouse model
associated with colorectal cancer; DNA:mutation:cds:
associated with Fibrosarcoma;mRNA,protein:decreased expression::
associated with colorectal cancer;DNA:mutations: :
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:3552201 PMID:8635384 PMID:26210240 PMID:27264476 PMID:27431311 More... RGD:11086960 RGD:11570402 RGD:14398745 RGD:14398751 RGD:152995400 NCBI chr 5:48,508,774...48,546,260
Ensembl chr 5:48,508,811...48,549,358 		JBrowse link
G KRT20 keratin 20 ISO associated with Colorectal Neoplasms RGD PMID:10931219 RGD:2317676 NCBI chr12:21,584,683...21,593,583
Ensembl chr12:21,584,814...21,594,854 		JBrowse link
G L1CAM L1 cell adhesion molecule treatment ISO associated with Lung Neoplasms;
associated with Pancreatic Neoplasms;		 RGD PMID:22095073 PMID:22307136 RGD:11570404 RGD:11570503 NCBI chr  X:124,595,649...124,618,292
Ensembl chr  X:124,595,651...124,618,307 		JBrowse link
G LAMC2 laminin subunit gamma 2 ISO associated with lung adenocarcinoma; RGD PMID:25591736 RGD:11075980 NCBI chr 9:124,427,545...124,499,672
Ensembl chr 9:124,435,807...124,495,351 		JBrowse link
G LCN2 lipocalin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24570342 NCBI chr 1:268,609,975...268,614,651
Ensembl chr 1:268,609,887...268,614,644 		JBrowse link
G LECT2 leukocyte cell derived chemotaxin 2 ISO CTD Direct Evidence: therapeutic CTD PMID:30453282 NCBI chr 2:138,109,537...138,120,285
Ensembl chr 2:138,109,351...138,124,464 		JBrowse link
G LEF1 lymphoid enhancer binding factor 1 ISO associated with prostate cancer
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:27067790 PMID:27811057 RGD:11531513 NCBI chr 8:113,824,511...113,944,078
Ensembl chr 8:113,825,161...113,944,070 		JBrowse link
G LGALS3 galectin 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25882088 NCBI chr 1:184,478,639...184,496,155
Ensembl chr 1:184,478,710...184,497,951 		JBrowse link
G LLGL2 LLGL scribble cell polarity complex component 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28114269 NCBI chr12:5,809,066...5,846,165
Ensembl chr12:5,809,069...5,846,162 		JBrowse link
G LOC100511937 phosphatidylinositol 3-kinase regulatory subunit gamma ISO associated with Adenocarcinoma, Colon RGD PMID:24837077 RGD:13432045 NCBI chr 6:165,268,260...165,402,668
Ensembl chr 6:165,268,568...165,402,649 		JBrowse link
G LOC100516084 cytoplasmic tRNA 2-thiolation protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27811057 NCBI chr 6:58,388,646...58,396,509 JBrowse link
G LOC100524391 putative methyltransferase NSUN6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28114269 NCBI chr10:44,884,179...44,958,024
Ensembl chr10:44,891,257...44,958,004 		JBrowse link
G LOC110255312 keratin, type I cytoskeletal 14 ISO mRNA:decreased expression:epithelial cell RGD PMID:9876218 RGD:1600180 NCBI chr12:21,074,965...21,079,393
Ensembl chr12:21,074,850...21,079,391 		JBrowse link
G LOC396867 stefin A8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20461718 NCBI chr13:138,216,027...138,226,397
Ensembl chr13:138,181,723...138,236,860 		JBrowse link
G LY96 lymphocyte antigen 96 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22180778 NCBI chr 4:61,919,806...61,950,712
Ensembl chr 4:61,926,064...61,950,697 		JBrowse link
G MACC1 MET transcriptional regulator MACC1 treatment ISO associated with stomach cancer; human cells in mouse model
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:27431311 PMID:36008464 RGD:152995400 NCBI chr 9:89,130,971...89,342,181
Ensembl chr 9:89,102,621...89,210,281 		JBrowse link
G MAP2K4 mitogen-activated protein kinase kinase 4 disease_progression ISO associated with oral squamous cell carcinoma;mRNA, protein:increased expression:lymph node (human) RGD PMID:22165133 RGD:150429749 NCBI chr12:56,402,029...56,516,217
Ensembl chr12:56,402,075...56,516,238 		JBrowse link
G MAPK1 mitogen-activated protein kinase 1 treatment ISO associated with prostate adenocarcinoma
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:22139534 PMID:22580338 RGD:13504820 NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513 		JBrowse link
G MAPK3 mitogen-activated protein kinase 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22580338 NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567 		JBrowse link
G MAPK9 mitogen-activated protein kinase 9 ISO associated with Colorectal Neoplasms
CTD Direct Evidence: therapeutic		 RGD
CTD		 PMID:21779479 PMID:25205654 RGD:13217416 NCBI chr 2:78,338,466...78,399,108
Ensembl chr 2:78,338,376...78,399,100 		JBrowse link
G MED28 mediator complex subunit 28 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21942447 NCBI chr 8:12,624,096...12,633,251
Ensembl chr 8:12,624,109...12,635,334 		JBrowse link
G MET MET proto-oncogene, receptor tyrosine kinase disease_progression ISO associated with Squamous Cell Carcinoma of the Tongue;
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:20080979 PMID:21225626 PMID:22704061 RGD:8548616 NCBI chr18:29,426,044...29,541,526
Ensembl chr18:29,426,048...29,541,512 		JBrowse link
G MIR100 microRNA mir-100 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr 9:49,157,909...49,157,988
Ensembl chr 9:49,157,909...49,157,988 		JBrowse link
G MIR125A microRNA mir-125a ISO associated with stomach cancer;
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:19487542 PMID:30117667 RGD:21403678 NCBI chr 6:58,331,566...58,331,645
Ensembl chr 6:58,331,566...58,331,645 		JBrowse link
G MIR130A microRNA mir-130a ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr 2:13,296,695...13,296,773
Ensembl chr 2:13,296,695...13,296,773 		JBrowse link
G MIR136 microRNA mir-136 ameliorates ISO associated with stomach cancer;human cells in mouse model RGD PMID:28656883 RGD:153344628 NCBI chr 7:121,711,328...121,711,409
Ensembl chr 7:121,711,325...121,711,414 		JBrowse link
G MIR148B microRNA mir-148b ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr 5:19,530,990...19,531,069
Ensembl chr 5:19,530,985...19,531,074 		JBrowse link
G MIR152 microRNA mir-152 ISO associated with Castration-Resistant Prostatic Neoplasms RGD PMID:23574937 RGD:19165145 NCBI chr12:24,292,249...24,292,328
Ensembl chr12:24,292,251...24,292,336 		JBrowse link
G MIR155 microRNA mir-155 ISO CTD Direct Evidence: marker/mechanism RGD
CTD		 PMID:19487542 PMID:27692344 PMID:27856635 RGD:21079446 NCBI chr13:189,138,822...189,138,902
Ensembl chr13:189,138,822...189,138,902 		JBrowse link
G MIR181C microRNA mir-181c ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr 2:65,279,950...65,280,036
Ensembl chr 2:65,279,944...65,280,040 		JBrowse link
G MIR193A microRNA mir-193a exacerbates ISO associated with colorectal cancer; miRNA:decreased expression:colorectum (human)
associated with lung non-small cell carcinoma; human cells in mouse model		 RGD PMID:24469061 PMID:25232258 PMID:30685413 RGD:153344566 RGD:153344592 RGD:153344599 NCBI chr12:43,336,969...43,337,048
Ensembl chr12:43,336,969...43,337,048 		JBrowse link
G MIR19A microRNA mir-19a ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr11:60,734,939...60,735,020
Ensembl chr11:60,734,939...60,735,020 		JBrowse link
G MIR205 microRNA mir-205 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr 9:133,517,078...133,517,146
Ensembl chr 9:133,517,078...133,517,146 		JBrowse link
G MIR20A microRNA mir-20a ISO associated with colorectal cancer RGD PMID:27286257 RGD:25823157 NCBI chr11:60,735,109...60,735,179
Ensembl chr11:60,735,099...60,735,196 		JBrowse link
G MIR20B-1 microRNA mir-20b-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr  X:110,113,980...110,114,059
Ensembl chr  X:110,113,980...110,114,059 		JBrowse link
G MIR21 microRNA mir-21 ameliorates
treatment		 ISO human cells in mouse model;associated with breast cancer
CTD Direct Evidence: marker/mechanism
associated with prostate carcinoma; human cells in mouse model		 RGD
CTD		 PMID:18270520 PMID:26101800 PMID:32736696 RGD:152998873 RGD:152998897 NCBI chr12:36,065,267...36,065,358
Ensembl chr12:36,065,267...36,065,358 		JBrowse link
G MIR221 microRNA mir-221 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr  X:40,571,068...40,571,137
Ensembl chr  X:40,571,068...40,571,137 		JBrowse link
G MIR222 microRNA mir-222 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr  X:40,571,808...40,571,887
Ensembl chr  X:40,571,808...40,571,887 		JBrowse link
G MIR224 microRNA mir-224 ISO CTD Direct Evidence: marker/mechanism
associated with colorectal cancer; mRNA:increased expression:colorectal mucosa:		 CTD
RGD		 PMID:19487542 PMID:25919696 RGD:14398749 NCBI chr  X:123,283,427...123,283,507
Ensembl chr  X:123,283,427...123,283,507 		JBrowse link
G MIR30A microRNA mir-30a ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr 1:51,412,827...51,412,933
Ensembl chr 1:51,412,827...51,412,933 		JBrowse link
G MIR30E microRNA mir-30e ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr 6:170,429,841...170,429,920
Ensembl chr 6:170,429,841...170,429,920 		JBrowse link
G MIR31 microRNA mir-31 disease_progression
treatment		 ISO CTD Direct Evidence: marker/mechanism
associated with colorectal cancer;RNA:increased expression:colorectum (human)
associated with stomach cancer;human cells in mouse model		 CTD
RGD		 PMID:19487542 PMID:26497852 PMID:27174918 PMID:30108104 RGD:153297776 RGD:153297806 RGD:153297811 NCBI chr 1:201,198,732...201,198,809
Ensembl chr 1:201,198,732...201,198,809 		JBrowse link
G MIR335 microRNA mir-335 ISO lung metastasis RGD PMID:21822301 RGD:14394425 NCBI chr18:18,341,580...18,341,659
Ensembl chr18:18,341,568...18,341,659 		JBrowse link
G MIR342 microRNA mir-342 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr 7:121,021,761...121,021,840
Ensembl chr 7:121,021,761...121,021,840 		JBrowse link
G MIR34C-1 microRNA mir-34c-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr 9:39,280,278...39,280,357
Ensembl chr 9:39,280,278...39,280,357 		JBrowse link
G MIR532 microRNA mir-532 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr  X:43,705,258...43,705,337
Ensembl chr  X:43,705,258...43,705,337 		JBrowse link
G MIR885 microRNA mir-885 ISO CTD Direct Evidence: therapeutic CTD PMID:27738331 NCBI chr13:66,597,531...66,597,610
Ensembl chr13:66,597,531...66,597,610 		JBrowse link
G MIR96 microRNA mir-96 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr18:18,982,506...18,982,590
Ensembl chr18:18,982,506...18,982,590 		JBrowse link
G MIR99A microRNA mir-99a ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr13:181,302,483...181,302,562
Ensembl chr13:181,302,478...181,302,567 		JBrowse link
G MIR99B microRNA mir-99b ISO CTD Direct Evidence: marker/mechanism CTD PMID:19487542 NCBI chr 6:58,332,211...58,332,280
Ensembl chr 6:58,332,205...58,332,284 		JBrowse link
G MKI67 marker of proliferation Ki-67 ISO associated with Pancreatic Neoplasms RGD PMID:20388395 RGD:2317702 NCBI chr14:137,266,622...137,296,312 JBrowse link
G MLH1 mutL homolog 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17717427 NCBI chr13:21,791,276...21,877,789
Ensembl chr13:21,791,203...21,877,757 		JBrowse link
G MMP1 matrix metallopeptidase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12538496 PMID:19487542 PMID:22580338 PMID:23548910 NCBI chr 9:33,411,738...33,420,205
Ensembl chr 9:33,411,065...33,420,076 		JBrowse link
G MMP13 matrix metallopeptidase 13 ISO associated with Carcinoma, Renal Cell;mRNA, protein:increased expression:bone RGD PMID:18709334 RGD:2306080 NCBI chr 9:33,549,003...33,616,700
Ensembl chr 9:33,549,008...33,561,162 		JBrowse link
G MMP2 matrix metallopeptidase 2 disease_progression ISO CTD Direct Evidence: marker/mechanism
associated with Mammary Neoplasms, Animal;protein:increased expression:brain
associated with pancreatic cancer; protein:increased expression, increased activity:pancreas
associated with Gallbladder Neoplasms; protein:increased expression:gallbladder		 CTD
RGD		 PMID:12173379 PMID:16158251 PMID:16475674 PMID:18398872 PMID:18665467 More... RGD:2325743 RGD:2325749 RGD:8547884 NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,595...30,086,982 		JBrowse link
G MMP24 matrix metallopeptidase 24 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27869830 NCBI chr17:38,587,230...38,636,628
Ensembl chr17:38,588,081...38,636,627 		JBrowse link
G MMP9 matrix metallopeptidase 9 severity
disease_progression		 ISO associated with Mammary Neoplasms, Animal
CTD Direct Evidence: marker/mechanism
associated with osteosarcoma;protein:increased expression:bone (human)
associated with pancreatic cancer; protein:increased expression, increased activity:pancreas
associated with skin melanoma;DNA:missense mutation:cds:p.Q279R (human)
associated with Mammary Neoplasms, Animal;protein:increased expression:brain
associated with Mammary Neoplasms, Animal; associated with Arthritis, Experimental
associated with Melanoma
associated with carcinoma, pancreatic ductal; protein:increased expression:pancreas		 RGD
CTD		 PMID:8912869 PMID:12173379 PMID:15659795 PMID:16033831 PMID:16158251 More... RGD:152023746